About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Atorvastatin Calcium Trihydrate
- Company
- Daiichi Sankyo
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 71 recruiting
Efficacy results: Not yet reported
71 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026
Find a Clinical Trial Near Me
See recruiting studies for Atorvastatin Calcium Trihydrate and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT03753555
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
Not yet reported General Hospital of Shenyang Military Region 100 participants Est. completion 2027-11-30 1 site Stand-aloneCardiovascular disease Other conditions: Atherosclerosis, CerebralView official trial listing → -
Recruiting NCT NCT03770702
Statins and ARBs on Rheumatoid Activity
Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2026-12-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT03819101
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 1210 participants Est. completion 2042-03 30 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT04147286
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Not yet reported, Not yet reported University of Cape Town 220 participants Est. completion 2027-09-30 1 siteOther conditions: Tuberculosis, PulmonaryView official trial listing → -
Recruiting NCT NCT04262206
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Not yet reported Duke University 20000 participants Est. completion 2026-12-31 106 sites Stand-aloneCardiovascular disease Other conditions: Cognitive Impairment, Mild, DementiaView official trial listing → -
Recruiting NCT NCT04347434
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
Not yet reported Penza State University 300 participants Est. completion 2027-12-30 1 site Stand-aloneCardiovascular disease Other conditions: Myocardial Strain, Arterial Stiffness, Quality of LifeView official trial listing → -
Recruiting NCT NCT04601116
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Not yet reported Aarhus University Hospital 3360 participants Est. completion 2035-01-01 1 siteOther conditions: Breast Cancer Female, Estrogen Receptor Positive TumorView official trial listing → -
Recruiting NCT NCT04735263
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
Not yet reported Massachusetts Eye and Ear Infirmary 21 participants Est. completion 2028-01-01 1 siteOther conditions: Age-related Macular DegenerationView official trial listing → -
Recruiting NCT NCT04765137
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
Not yet reported Johns Hopkins University 20 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Mild Cognitive ImpairmentView official trial listing → -
Recruiting NCT NCT04847752
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Tongji Hospital 1000 participants Est. completion 2028-12-31 1 siteCardiovascular disease Other conditions: Large-Artery Atherosclerosis (Embolus/Thrombosis)View official trial listing → -
Recruiting NCT NCT04915183
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Not yet reported National Institute on Deafness and Other Communication Disorders (NIDCD) 224 participants Est. completion 2030-08-31 5 sites Stand-aloneOther conditions: Hearing Loss, Head and Neck CancerView official trial listing → -
Recruiting NCT NCT04968509
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
Not yet reported Beijing Anzhen Hospital 160 participants Est. completion 2028-01 1 site Stand-aloneOther conditions: Aortic StenosisView official trial listing → -
Recruiting NCT NCT05028829
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Not yet reported Raymond Chung 60 participants Est. completion 2031-03-01 2 sites Stand-aloneOther conditions: Liver Fibroses, CirrhosisView official trial listing → -
Recruiting NCT NCT05030818
Cross-over Study of Coronary Risk Factors With a Polypill
Not yet reported Fundación EPIC 88 participants Est. completion 2026-04-30 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT05076019
Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement
Not yet reported Odense University Hospital 266 participants Est. completion 2027-12-01 1 site Stand-aloneOther conditions: Postoperative Atrial FibrillationView official trial listing → -
Recruiting NCT NCT05289063
Vascular Endothelial Dysfunction in Sleep Apnea
Not yet reported Columbia University 110 participants Est. completion 2027-02-28 1 siteObstructive sleep apneaView official trial listing → -
Recruiting NCT NCT05365438
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Not yet reported Seoul National University Bundang Hospital 105 participants Est. completion 2026-12-31 1 site Stand-aloneType 2 diabetes Other conditions: Dyslipidemias, AtherosclerosisView official trial listing → -
Recruiting NCT NCT05397405
Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome
Not yet reported Nanjing First Hospital, Nanjing Medical University 180 participants Est. completion 2026-05-01 2 sites Stand-aloneOther conditions: Intracranial Artery StenosisView official trial listing → -
Recruiting NCT NCT05404139
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
Not yet reported University Health Network, Toronto 352 participants Est. completion 2031-02 2 sites Stand-aloneOther conditions: Metastatic Prostate CancerView official trial listing → -
Recruiting NCT NCT05483010
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Not yet reported Washington University School of Medicine 16 participants Est. completion 2028-05-31 1 site Stand-aloneOther conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic SyndromesView official trial listing → -
Recruiting NCT NCT05559164
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Not yet reported Rutgers, The State University of New Jersey 60 participants Est. completion 2027-03-01 10 sites Stand-aloneOther conditions: Cardiac Toxicity, Early-stage Breast CancerView official trial listing → -
Recruiting NCT NCT05641753
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Not yet reported NYU Langone Health 125 participants Est. completion 2027-07-31 4 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Recruiting NCT NCT05705804
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
Not yet reported Yonsei University 250 participants Est. completion 2027-06-01 1 siteCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Recruiting NCT NCT05796973
Measuring Oncological Value of Exercise and Statin
Not yet reported Tampere University Hospital 240 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Prostate Cancer, Breast Cancer, Kidney Cancer, Ovarian Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, Metastatic Prostate Cancer, Metastatic Prostate Adenocarcinoma, Metastatic Ovarian Cancer, Metastatic Ovary CancerView official trial listing → -
Recruiting NCT NCT06102863
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Not yet reported Peking University People's Hospital 38 participants Est. completion 2025-09-01 1 site Stand-aloneOther conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage IView official trial listing → -
Recruiting NCT NCT06199921
ATORvastatin in Pulmonary TUBerculosis
Not yet reported Obafemi Awolowo University Teaching Hospital 440 participants Est. completion 2026-09-30 8 sites Stand-aloneOther conditions: Pulmonary Tuberculosis, Tuberculosis, Koch's DiseaseView official trial listing → -
Recruiting NCT NCT06248671
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Not yet reported St. Olavs Hospital 450 participants Est. completion 2029-02-28 6 sitesOther conditions: Episodic MigraineView official trial listing → -
Recruiting NCT NCT06308952
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
Not yet reported Duan Chuanzhi 354 participants Est. completion 2027-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Cerebrovascular Event, Stent Stenosis, Stent Thrombosis, Death, Brain, Endothelial DysfunctionView official trial listing → -
Recruiting NCT NCT06312748
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
Not yet reported VA Office of Research and Development 90 participants Est. completion 2030-09-30 1 site Stand-aloneHeart failure Other conditions: InflammationView official trial listing → -
Recruiting NCT NCT06327451
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Not yet reported Tianjin Medical University General Hospital 50 participants Est. completion 2027-02-28 1 site Stand-aloneOther conditions: Glioblastoma, IDH-wildtypeView official trial listing → -
Recruiting NCT NCT06336174
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Anhui Medical University 100 participants Est. completion 2026-12-31 1 siteOther conditions: Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular EventView official trial listing → -
Recruiting NCT NCT06358313
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
Not yet reported Kafrelsheikh University 600 participants Est. completion 2026-05-30 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06360120
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Not yet reported Kafrelsheikh University 600 participants Est. completion 2025-10-01 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06485336
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
Not yet reported St. Olavs Hospital 300 participants Est. completion 2029-02-28 6 sitesOther conditions: Chronic MigraineView official trial listing → -
Recruiting NCT NCT06501443
LATAM LOWERS LDL-C
Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Recruiting NCT NCT06604117
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
Xuanwu Hospital, Beijing 200 participants Est. completion 2027-10 1 siteCardiovascular disease Other conditions: Atherosclerosis of Artery, Lipid Disorder, StatinView official trial listing → -
Recruiting NCT NCT06632379
AtorvaStatin Postpartum and Reduction of Cardiovascular risK
Not yet reported Ohio State University 76 participants Est. completion 2026-12-15 1 siteOther conditions: Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational HypertensionView official trial listing → -
Recruiting NCT NCT06690164
Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone
Not yet reported National University Hospital, Singapore 78 participants Est. completion 2026-06 1 site Stand-aloneOther conditions: MetaboliteView official trial listing → -
Recruiting NCT NCT06750783
The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes
Not yet reported Beijing Tsinghua Chang Gung Hospital 398 participants Est. completion 2026-03-31 3 sites Stand-aloneOther conditions: Prediabetic State (IGT)View official trial listing → -
Recruiting NCT NCT06764966
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
Not yet reported CAMC Health System 50 participants Est. completion 2027-03 1 siteOther conditions: Decompensated Liver Cirrhosis, Cirrhosis, Decompensated Cirrhosis of Liver, Decompensated Cirrhosis and AscitesView official trial listing → -
Recruiting NCT NCT06765265
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Not yet reported King Edward Medical University 152 participants Est. completion 2026-01-01 1 siteOther conditions: Acute Coronary SyndromesView official trial listing → -
Recruiting NCT NCT06784557
Effect of Ezetimibe on Gut Microbiota
Not yet reported Yonsei University 110 participants Est. completion 2025-10-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06785740
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 300 participants Est. completion 2029-09 4 sitesCardiovascular disease Other conditions: TIAView official trial listing → -
Recruiting NCT NCT06858332
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Novartis Pharmaceuticals 2382 participants Est. completion 2027-09-30 20 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06896708
Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome
Not yet reported Liu yong 766 participants Est. completion 2028-03-01 7 sites Stand-aloneOther conditions: Chronic Coronary SyndromeView official trial listing → -
Recruiting NCT NCT06902740
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2028-12-31 19 sites Stand-aloneOther conditions: Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic PlaqueView official trial listing → -
Recruiting NCT NCT06922994
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
Not yet reported Centro Cardiologico Monzino 102 participants Est. completion 2026-11-30 5 sitesOther conditions: Arrhythmogenic CardiomyopathyView official trial listing → -
Recruiting NCT NCT06930885
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Not yet reported Hospital do Coracao 7713 participants Est. completion 2031-05 13 sites Stand-aloneCardiovascular disease Other conditions: Atherothrombotic DiseasesView official trial listing → -
Recruiting NCT NCT06961630
Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction
Not yet reported NYU Langone Health 50 participants Est. completion 2027-03-31 1 site Stand-aloneOther conditions: Myocardial Injury After Noncardiac SurgeryView official trial listing → -
Recruiting NCT NCT06975111
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sitesOther conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, CardiovascularView official trial listing → -
Recruiting NCT NCT07012629
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
Not yet reported Aarhus University Hospital 1652 participants Est. completion 2040-01-01 14 sites Stand-aloneOther conditions: Covert Brain InfarctionView official trial listing → -
Recruiting NCT NCT07036991
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis
Changhai Hospital 406 participants Est. completion 2027-06-01 1 siteOther conditions: Carotid Artery StenosisView official trial listing → -
Recruiting NCT NCT07045142
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
Not yet reported Central South University 400 participants Est. completion 2028-06-01 8 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT07083206
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 siteOther conditions: Hypercholesterolemia, DyslipidemiasView official trial listing → -
Recruiting NCT NCT07088250
Statins for Treatment of Primary Intracerebral Hemorrhage
Not yet reported The Second Hospital of Anhui Medical University 264 participants Est. completion 2026-12-31 22 sites Stand-aloneOther conditions: Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral HaemorrhageView official trial listing → -
Recruiting NCT NCT07265466
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Not yet reported Onconic Therapeutics Inc. 96 participants Est. completion 2026-03-30 1 site Stand-aloneOther conditions: Drug Drug Interaction (DDI)View official trial listing → -
Recruiting NCT NCT07303699
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
Not yet reported Obafemi Awolowo University Teaching Hospital 80 participants Est. completion 2028-03-30 3 sites Stand-aloneOther conditions: Pulmonary Tuberculosis (TB)View official trial listing → -
Recruiting NCT NCT07307989
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2029-07-31 1 site Stand-aloneCardiovascular disease Other conditions: HypercholesteremiaView official trial listing → -
Recruiting NCT NCT07344610
Effects of Short-term Intensive Statin Therapy on Lipid Levels
General Hospital of Shenyang Military Region 800 participants Est. completion 2026-12-30 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07359105
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Not yet reported Sin Gon Kim 2186 participants Est. completion 2029-12-31 2 sites Stand-aloneOther conditions: Dyslipidemia Associated With Type II Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07400757
Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease
Not yet reported Taipei Veterans General Hospital, Taiwan 120 participants Est. completion 2032-07-15 1 site Stand-aloneOther conditions: Thyroid Eye Disease, TED, Graves OphthalmopathyView official trial listing → -
Recruiting NCT NCT07524101
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Not yet reported Yonsei University 1952 participants Est. completion 2031-01-22 1 site Stand-aloneCardiovascular disease Other conditions: Renal Insufficiency, Atherosclerosis, Dyslipidemia, HypercholesterolemiaView official trial listing → -
Recruiting NCT NCT07530640
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
Not yet reported Children's Hospital of Fudan University 9 participants Est. completion 2027-09-30 1 site Stand-aloneOther conditions: Kawasaki Disease, Coronary Artery AbnormalitiesView official trial listing → -
Recruiting NCT NCT07554820
Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
Not yet reported Shaikh Zayed Hospital, Lahore 120 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: Rheumatoid Arthritis, Major Adverse Cardiac EventsView official trial listing → -
Recruiting NCT NCT07611747
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Not yet reported Instituto de Investigación Marqués de Valdecilla 1944 participants Est. completion 2031-12 17 sites Stand-aloneOther conditions: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular Disease, Atherosclerosis, Carotid Artery DiseasesView official trial listing → -
Recruiting NCT NCT07680595
Prospective Management of Plaque Instability With Statins and Extra Folic Acid
Not yet reported, Not yet reported Ruijin Hospital 180 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Carotid Atherosclerotic PlaqueView official trial listing → -
Recruiting NCT NCT07685938
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Not yet reported UNC Lineberger Comprehensive Cancer Center 60 participants Est. completion 2029-02 1 site Stand-aloneOther conditions: Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor, Thoracic Cancer, Thoracic NeoplasmsView official trial listing → -
Recruiting NCT NCT07704918
Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: MelanomaView official trial listing → -
Recruiting NCT NCT07727681
Perioperative Statins to Prevent AFib After Lung Surgery
Not yet reported Peking Union Medical College Hospital 540 participants Est. completion 2028-01-02 2 sites Stand-aloneOther conditions: Postoperative Atrial Fibrillation, Lung SurgeryView official trial listing → -
Recruiting NCT NCT07785934
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
Not yet reported The United Bio-Technology (Hengqin) Co., Ltd. 48 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Drug Drug Interaction (DDI), Pharmacokinetics and PharmacodynamicsView official trial listing → -
Recruiting NCT NCT07824323
Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome
Not yet reported Taipei Medical University Hospital 400 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Acute Coronary Syndromes, DyslipidemiaView official trial listing → -
Completed NCT NCT00000941
A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants Est. completion 2002-03 13 sitesOther conditions: HIV InfectionsView official trial listing → -
Terminated NCT NCT00004466
Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5 participants Est. completion 1999-12 1 site Stand-aloneOther conditions: Nephrotic Syndrome, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT00004564
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Not yet reported National Center for Research Resources (NCRR) 1 siteOther conditions: Hypercholesterolemia, ThrombosisView official trial listing → -
Completed NCT NCT00017758
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants 10 sitesOther conditions: HIV Infections, HIV Seronegativity, LipodystrophyView official trial listing → -
Completed NCT NCT00023231
Pediatric Kidney Transplant Without Calcineurin Inhibitors
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2006-08 1 siteOther conditions: End-Stage Renal DiseaseView official trial listing → -
Completed NCT NCT00024531
Lipitor as a Treatment for Alzheimer's Disease
Not yet reported Institute for the Study of Aging (ISOA) 98 participants Est. completion 2004-08 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00065806
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
Not yet reported Laura Schanberg 221 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Lupus Erythematosus, SystemicView official trial listing → -
Completed NCT NCT00072826
Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease
Not yet reported National Institutes of Health Clinical Center (CC) 44 participants Est. completion 2007-08-24 1 siteOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT00079638
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Not yet reported Kos Pharmaceuticals 300 participants Est. completion 2005-05Cardiovascular disease Other conditions: Dyslipidemia, Coronary Heart Disease, Atherosclerosis, DiabetesView official trial listing → -
Completed NCT NCT00081731
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Not yet reported Baim Institute for Clinical Research 947 participants Est. completion 2013-09 1 siteCardiovascular disease Other conditions: Atherosclerosis, Hypertension, Renovascular, Renal Artery ObstructionView official trial listing → -
Completed NCT NCT00090168
Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)
Not yet reported Organon and Co 435 participants Est. completion 2004-11-10Other conditions: Hypercholesterolemia, Atherosclerotic Disease, Coronary DiseaseView official trial listing → -
Completed NCT NCT00092625
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)
Not yet reported Organon and Co 442 participants Est. completion 2004-08Other conditions: Hypercholesterolemia, Coronary DiseaseView official trial listing → -
Completed NCT NCT00092638
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
Not yet reported Organon and Co 450 participants Est. completion 2004-08Other conditions: Hypercholesterolemia, Coronary DiseaseView official trial listing → -
Completed NCT NCT00092690
MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)
Not yet reported Organon and Co 1902 participants Est. completion 2004-03Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00092716
Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)
Not yet reported Organon and Co 655 participants Est. completion 2003-04Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00094172
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 82 participants Est. completion 2009-05 14 sites Stand-aloneOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00103974
Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Not yet reported Bayhill Therapeutics 30 participants Est. completion 2007-03 4 sitesOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00110435
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
Not yet reported Organon and Co 1229 participants Est. completion 2005-12Type 2 diabetes Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00115817
The Effects of Atorvastatin in Patients With Atherosclerosis
Not yet reported Brigham and Women's Hospital 36 participants Est. completion 2007-03 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00115830
Rho Kinase in Patients With Atherosclerosis
Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2007-02 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00120055
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
Not yet reported University of Oslo School of Pharmacy Est. completion 2005-04Other conditions: MyopathyView official trial listing → -
Completed NCT NCT00120133
Atorvastatin (Lipitor) to Prevent Bone Pain
Not yet reported Children's Mercy Hospital Kansas City 12 participants Est. completion 2007-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00120887
Lupus Atherosclerosis Prevention Study
Not yet reported Johns Hopkins University 200 participants Est. completion 2005-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00124397
Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)
Not yet reported University of Southern Denmark 186 participants Est. completion 2004-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00126048
Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma
Not yet reported, Not yet reported University of Glasgow 54 participants Est. completion 2007-09 1 siteOther conditions: AsthmaView official trial listing → -
Completed NCT NCT00127218
High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
Not yet reported Johns Hopkins University 145 participants Est. completion 2008-12 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Withdrawn NCT NCT00127335
Is Myopathy Part of Statin Therapy (IMPOSTER-16)
Not yet reported Scripps Health Est. completion 2008-05 1 siteOther conditions: Myopathic ConditionsView official trial listing → -
Completed NCT NCT00130481
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
Not yet reported University of Florida 100 participants Est. completion 2007-04 1 siteType 2 diabetes Other conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00132717
A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
Not yet reported Organon and Co 450 participants Est. completion 2007-06-01Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00133380
A Study in People With High Cholesterol
Not yet reported Eli Lilly and Company 300 participants Est. completion 2006-09 28 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00134173
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
Not yet reported Pfizer 1100 participants Est. completion 2006-09 146 sitesOther conditions: Coronary Disease, Coronary Arteriosclerosis, HyperlipidemiaView official trial listing → -
Terminated NCT NCT00134238
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
Not yet reported Pfizer 755 participants Est. completion 2006-12 51 sitesOther conditions: Mixed HyperlipidemiaView official trial listing → -
Terminated NCT NCT00134264
A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
Not yet reported Pfizer 15067 participants Est. completion 2007-06 221 sitesOther conditions: Coronary Disease, Diabetes MellitusView official trial listing → -
Completed NCT NCT00134485
Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia
Not yet reported Pfizer 400 participants Est. completion 2006-03 41 sitesOther conditions: Hypercholesterolemia, Familial, HyperlipidemiaView official trial listing → -
Completed NCT NCT00134498
A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides
Not yet reported Pfizer 160 participants Est. completion 2006-11 44 sitesOther conditions: Hypertriglyceridemia, Hyperlipoproteinemia Type IVView official trial listing → -
Completed NCT NCT00134511
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
Not yet reported Pfizer 30 participants Est. completion 2005-11 6 sitesOther conditions: Hypercholesterolemia, FamilialView official trial listing → -
Completed NCT NCT00134550
Improving Diabetic Foot Ulcers With Atorvastatin
Not yet reported Asker & Baerum Hospital 13 participants Est. completion 2007-03 2 sitesOther conditions: Foot Ulcer, DiabetesView official trial listing → -
Completed NCT NCT00136942
A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 370 participants 20 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00136981
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.
Not yet reported Pfizer 800 participants Est. completion 2006-11 34 sitesOther conditions: Hypercholesterolemia, Familial, HyperlipidemiaView official trial listing → -
Completed NCT NCT00137176
EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2008-10 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00137462
Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.
Not yet reported Pfizer 900 participants Est. completion 2006-09 59 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00138762
A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol
Not yet reported Pfizer 3800 participants Est. completion 2006-08 154 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00139061
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
Not yet reported Pfizer 128 participants Est. completion 2006-05 26 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00141141
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 383 participants Est. completion 2007-04 35 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00141232
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 810 participants Est. completion 2006-07 59 sitesOther conditions: Diabetes, Type 2View official trial listing → -
Completed NCT NCT00143234
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1825 participants Est. completion 2005-07 118 sitesOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT00143676
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
Not yet reported Takeda 448 participants Est. completion 2006-08 78 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00143741
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
Not yet reported University of Chicago 20 participants Est. completion 2011-07 1 siteOther conditions: End-Stage Kidney DiseaseView official trial listing → -
Terminated NCT NCT00145431
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
Not yet reported Pfizer 41 participants Est. completion 2006-12 27 sitesOther conditions: Hyperlipoproteinemia Type IIIView official trial listing → -
Completed NCT NCT00147602
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
Not yet reported Pfizer 4732 participants Est. completion 2005-11 130 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00150371
Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1100 participants Est. completion 2005-05 84 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00150384
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2005-08 106 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00150722
High-Density Lipoprotein (HDL) Modulation and Endothelial Function
Not yet reported University of Calgary 75 participants Est. completion 2008-08 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00150943
Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis
Not yet reported UMC Utrecht 140 participants 1 siteOther conditions: Renal Artery Obstruction, Kidney FailureView official trial listing → -
Completed NCT NCT00151502
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600 participants Est. completion 2007-07 99 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00153166
ARREST PAD (Peripheral Arterial Disease)
Not yet reported, Not yet reported Brigham and Women's Hospital 76 participants Est. completion 2011-12 1 site Stand-aloneAlcohol use disorder Other conditions: Arterial Occlusive Disease, Insulin ResistanceView official trial listing → -
Completed NCT NCT00154024
Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.
Not yet reported Technische Universität Dresden Est. completion 2006-10 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT00157924
Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
Not yet reported Organon and Co 190 participants Est. completion 2007-09Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00159718
Double Blind Atorvastatin Amlodipine Study
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 360 participants Est. completion 2007-01 33 sitesOther conditions: AnginaView official trial listing → -
Completed NCT NCT00159835
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD
Not yet reported Pfizer 8600 participants Est. completion 2005-03 194 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00163150
Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 128 participants Est. completion 2006-02 1 siteOther conditions: Cerebrovascular Accident, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00163163
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 400 participants Est. completion 2006-07 69 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00163202
Comparative Atorvastatin Pleiotropic Effects
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330 participants Est. completion 2005-08 74 sitesOther conditions: Coronary Arteriosclerosis, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00164086
Atorvastatin in Myeloma
Not yet reported Bayside Health 1 siteOther conditions: MyelomaView official trial listing → -
Completed NCT NCT00166036
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
Not yet reported Emory University 36 participants Est. completion 2009-04 1 site Stand-aloneMetabolic syndrome Other conditions: Diabetes Mellitus, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00166504
Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)
Not yet reported Organon and Co 203 participants Est. completion 2007-10Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00166530
EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
Not yet reported Organon and Co 367 participants Est. completion 2007-02Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00172419
The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.
Not yet reported National Taiwan University Hospital 43 participants Est. completion 2008-12 1 site Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00174304
Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1120 participants Est. completion 2006-09 102 sitesOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT00174330
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330 participants Est. completion 2006-02 15 sitesOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Terminated NCT NCT00181181
The Effect of Statin Use on Vascular Function in Hypertensive Subjects
Not yet reported Johns Hopkins University 24 participants Est. completion 2007-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00185731
Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Not yet reported Dean Felsher 25 participants Est. completion 2012-11 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Non-HodgkinView official trial listing → -
Completed NCT NCT00194402
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
Not yet reported University of Washington 64 participants Est. completion 2006-01 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00195793
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
Not yet reported Abbott 174 participantsOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00199745
Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
Not yet reported Oslo University Hospital 53 participants Est. completion 2008-12 1 siteOther conditions: Muscular DiseasesView official trial listing → -
Status unknown NCT NCT00201552
Statin and PAF in Patients With Pacemaker
Not yet reported National Taiwan University Hospital 1 siteOther conditions: Paroxysmal Atrial FibrillationView official trial listing → -
Completed NCT NCT00202904
Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
Not yet reported Organon and Co 81 participants Est. completion 2006-10 Stand-aloneOther conditions: Hypercholesterolemia, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00211939
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
Not yet reported Nabi Biopharmaceuticals 203 participants Est. completion 2007-03 1 site Stand-aloneOther conditions: Calcinosis, Arteriosclerosis, Hyperparathyroidism, SecondaryView official trial listing → -
Completed NCT NCT00214630
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
Not yet reported AstraZeneca 825 participants Est. completion 2007-08 56 sitesOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT00231803
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial
Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT00233480
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
Not yet reported University of California, Los Angeles 27 participants Est. completion 2009-02 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT00235950
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
Not yet reported AstraZeneca 255 participants Est. completion 2006-03 18 sitesOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00239330
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
Not yet reported AstraZeneca 824 participants Est. completion 2005-02 26 sitesOther conditions: HypercholesteremiaView official trial listing → -
Completed NCT NCT00241488
DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
Not yet reported AstraZeneca 1362 participants Est. completion 2007-02 34 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00242944
Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
Not yet reported Kyoto University 307 participants Est. completion 2008-03 3 sitesOther conditions: Coronary Disease, HypercholesterolemiaView official trial listing → -
Withdrawn NCT NCT00243672
Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
Not yet reported University Hospital Muenster 100 participants Est. completion 2007-10Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00249249
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
Not yet reported Kowa Research Europe 830 participants Est. completion 2006-11 192 sitesOther conditions: Primary Hypercholesterolemia, DyslipidemiaView official trial listing → -
Terminated NCT NCT00249899
Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia
Not yet reported Takeda 649 participants Est. completion 2007-03 23 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00251680
Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
Not yet reported Takeda 400 participants Est. completion 2007-05 77 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00252967
Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
Not yet reported Emory University 64 participants Est. completion 2009-10 3 sites Stand-aloneOther conditions: Atrial Fibrillation, InflammationView official trial listing → -
Completed NCT NCT00259662
High-dose Periop Statins for Prevention of DVT
Not yet reported Yale University 29 participants Est. completion 2007-08 1 siteOther conditions: Gynecologic Oncological Pelvic/Abdominal SurgeryView official trial listing → -
Completed NCT NCT00267254
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.
Not yet reported Pfizer 640 participants Est. completion 2006-08 49 sitesOther conditions: Hyperlipidemia, Dyslipidemia, HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00267267
A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
Not yet reported Pfizer 1784 participants Est. completion 2007-01 123 sitesOther conditions: Hyperlipidemia, DyslipidemiaView official trial listing → -
Terminated NCT NCT00267280
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).
Not yet reported Pfizer 640 participants Est. completion 2006-12 51 sitesOther conditions: Hyperlipidemia, Dyslipidemia, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00276133
Effects of Atorvastatin Versus Probucol on Small Dense LDL
Not yet reported Yokohama City University Medical Center 24 participants Est. completion 2007-05 1 siteOther conditions: Chronic NephropathyView official trial listing → -
Completed NCT NCT00276458
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
Not yet reported Organon and Co 196 participants Est. completion 2008-01 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00276484
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)
Not yet reported Organon and Co 579 participants Est. completion 2008-03 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00279708
Atorvastatin to Treat Pulmonary Sarcoidosis
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 55 participants Est. completion 2015-12 1 siteOther conditions: Sarcoidosis, PulmonaryView official trial listing → -
Completed NCT NCT00286312
Myocardial Infarction Size Reduction With Atorvastatin
Not yet reported R&D Cardiologie 50 participants Est. completion 2008-02 2 sitesCardiovascular disease Other conditions: Reperfusion InjuryView official trial listing → -
Completed NCT NCT00289900
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
Not yet reported Merck Sharp & Dohme LLC 2340 participants Est. completion 2010-08-06Other conditions: Mixed HyperlipidemiaView official trial listing → -
Terminated NCT NCT00292201
Statin Treatment in Patients With Asthma
Not yet reported Queen's University 10 participants Est. completion 2015-06 1 site Stand-aloneOther conditions: AsthmaView official trial listing → -
Completed NCT NCT00293748
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
National Institute of Neurological Disorders and Stroke (NINDS) 200 participants Est. completion 2008-12-15 1 siteOther conditions: Vascular Disease, Vascular Disease RiskView official trial listing → -
Completed NCT NCT00296374
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
Not yet reported AstraZeneca 353 participants Est. completion 2009-03 116 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00296387
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Not yet reported AstraZeneca 1160 participants Est. completion 2007-10 102 sitesOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00296400
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Not yet reported AstraZeneca 237 participants Est. completion 2009-06 107 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00297973
Cardiovascular Risk Assessment in Patients Treated With Caduet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1442 participants Est. completion 2007-04 384 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00299884
Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
Queen's University 45 participants Est. completion 2006-07 1 siteOther conditions: Dyslipidemia, Vascular DiseaseView official trial listing → -
Completed NCT NCT00300430
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Not yet reported Abbott 1911 participants 1 siteOther conditions: Dyslipidemia, Coronary Heart Disease, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00300469
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
Not yet reported Abbott 613 participants 1 siteOther conditions: Mixed Dyslipidemia, Coronary Heart Disease, DyslipidemiaView official trial listing → -
Completed NCT NCT00303277
Do HMG CoA Reductase Inhibitors Affect Abeta Levels?
Not yet reported Seattle Institute for Biomedical and Clinical Research 35 participants Est. completion 2005-04 1 siteOther conditions: Alzheimer's Disease, AgingView official trial listing → -
Completed NCT NCT00309751
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Not yet reported Kowa Research Europe 418 participants Est. completion 2007-06 35 sitesOther conditions: Type II Diabetes Mellitus, DyslipidemiaView official trial listing → -
Completed NCT NCT00317967
Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart
Not yet reported University of Calgary 22 participants Est. completion 2010-11 1 site Stand-aloneOther conditions: Hypertrophic CardiomyopathyView official trial listing → -
Completed NCT NCT00319449
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
Not yet reported Organon and Co 22 participants Est. completion 2006-10 Stand-aloneOther conditions: Hypercholesterolemia, Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT00327418
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
Not yet reported Pfizer 2800 participants Est. completion 2004-02 135 sitesOther conditions: Major Coronary Event, Cerebrovascular Accident, Coronary Artery Bypass Graft, Angina, Unstable, RevascularizationView official trial listing → -
Completed NCT NCT00327691
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
Not yet reported Pfizer 8600 participants Est. completion 2004-08 314 sitesCardiovascular disease Other conditions: Cerebrovascular Accident, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00329069
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
Not yet reported University of Ulm 50 participants Est. completion 2006-03 1 siteCardiovascular disease Other conditions: Hypercholesterolemia, Monocyte FunctionView official trial listing → -
Completed NCT NCT00329173
PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.
Not yet reported AstraZeneca 1000 participants Est. completion 2004-08Other conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00330785
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1250 participants Est. completion 2005-09 126 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00331565
Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin
Not yet reported University of Oslo School of Pharmacy 36 participants Est. completion 2010-12 1 siteOther conditions: Morbid ObesityView official trial listing → -
Completed NCT NCT00332761
Caduet in an Untreated Subject Population
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2007-09 34 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00335504
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
Not yet reported National Cancer Institute (NCI) 85 participants Est. completion 2009-04 1 site Stand-aloneOther conditions: Colon Cancer, Precancerous Condition, Rectal CancerView official trial listing → -
Completed NCT NCT00335699
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
Not yet reported AstraZeneca 370 participants Est. completion 2007-01 7 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00343655
Evaluation of Atorvastatin Treatment on Carotid Plaque.
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160 participants Est. completion 2007-08 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00344019
Effects of Atorvastatin on Myonecrosis
Not yet reported Beth Israel Deaconess Medical Center 97 participants Est. completion 2009-01 1 siteOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT00344370
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Not yet reported Kowa Research Europe 214 participants Est. completion 2008-04 35 sitesOther conditions: Type II Diabetes Mellitus, DyslipidemiaView official trial listing → -
Completed NCT NCT00344955
Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
Not yet reported Regional Hospital Holstebro 20 participants Est. completion 2003-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00345202
Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
Not yet reported Regional Hospital Holstebro 20 participants Est. completion 2005-02 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00355251
Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption
Not yet reported Germans Trias i Pujol Hospital 5 participants Est. completion 2007-02 1 site Stand-aloneOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00356473
Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis
Not yet reported University of California, Los Angeles 20 participants Est. completion 2005-09 Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00359281
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Not yet reported Aegerion Pharmaceuticals, Inc. 125 participants Est. completion 2007-11 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00361283
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
Not yet reported University of Florida 108 participants Est. completion 2009-01 1 siteOther conditions: InflammationView official trial listing → -
Completed NCT NCT00362934
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Not yet reported Solvay Pharmaceuticals 516 participants Est. completion 2008-08 68 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00367458
Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2008-06-19 3 sites Stand-aloneOther conditions: HIVView official trial listing → -
Completed NCT NCT00368589
Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
GlaxoSmithKline 47 participants Est. completion 2007-08 1 siteOther conditions: Atherosclerotic Carotid Disease, Atheroma, AtherosclerosisView official trial listing → -
Completed NCT NCT00375518
Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
Not yet reported Memorial Sloan Kettering Cancer Center 162 participants Est. completion 2014-05 1 siteOther conditions: Thoracic SurgeryView official trial listing → -
Completed NCT NCT00380939
This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.
Not yet reported Pfizer 600 participants Est. completion 2000-12 36 sitesOther conditions: Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT00382460
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
Not yet reported Bristol-Myers Squibb 4000 participants Est. completion 2003-12Other conditions: Actue Coronary SyndromesView official trial listing → -
Completed NCT NCT00388596
A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.
Not yet reported GlaxoSmithKline 36 participants 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00392717
Regulation of Lipoprotein Metabolism in Obese Men
Not yet reported The University of Western Australia 48 participants Est. completion 2002-03 1 siteOther conditions: Obesity, Dyslipidemia, Insulin ResistanceView official trial listing → -
Completed NCT NCT00395486
ROMEO (Rosuvastatin in Metabolic syndrOme)
Not yet reported AstraZeneca 258 participants Est. completion 2008-06 3 sitesMetabolic syndromeView official trial listing → -
Terminated NCT NCT00395603
Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
Not yet reported Organon and Co 550 participants Est. completion 2007-06Cardiovascular disease Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00396721
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Not yet reported Josep m Cruzado 23 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Glomerulonephritis, IGA, Nephropathy, IGA, IGA NephropathyView official trial listing → -
Completed NCT NCT00403533
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
Not yet reported Massachusetts General Hospital 10 participants Est. completion 2006-07 1 siteOther conditions: Hepatitis CView official trial listing → -
Status unknown NCT NCT00404599
Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
Not yet reported Amsterdam UMC, location VUmc 60 participants Est. completion 2009-07 1 siteOther conditions: Diabetes Mellitus, HypertensionView official trial listing → -
Completed NCT NCT00405717
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
Not yet reported Shenyang Northern Hospital 1300 participants Est. completion 2008-05 1 siteOther conditions: Ischemic Heart Disease, Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT00407537
Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1531 participants Est. completion 2009-10 125 sites Stand-aloneOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00408382
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
Not yet reported Astellas Pharma Inc 50 participants 2 sitesCardiovascular disease Other conditions: HypercholesteremiaView official trial listing → -
Completed NCT NCT00409773
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
Not yet reported Organon and Co 1143 participants Est. completion 2008-07Metabolic syndrome Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00411190
Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin
Not yet reported GlaxoSmithKline 32 participants Est. completion 2006-12-15 2 sites Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT00412113
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 245 participants Est. completion 2008-04 51 sites Stand-aloneOther conditions: Dyslipidemia, HypertensionView official trial listing → -
Terminated NCT NCT00412841
Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus
Not yet reported NYU Langone Health 43 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Avascular NecrosisView official trial listing → -
Completed NCT NCT00414531
Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
Not yet reported University of Oslo School of Pharmacy 53 participants Est. completion 2009-06 1 siteOther conditions: Myotoxicity of Atorvastatin TreatmentView official trial listing → -
Completed NCT NCT00418834
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
Not yet reported Organon and Co 1053 participants Est. completion 2008-10Other conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00427960
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
Not yet reported AstraZeneca 55 participants Est. completion 2008-02 9 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Status unknown NCT NCT00432354
An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus
Not yet reported, Not yet reported Buddhist Tzu Chi General Hospital 40 participants Est. completion 2009-03 2 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT00433823
A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis
Not yet reported Abant Izzet Baysal University Est. completion 2008-01 1 siteOther conditions: Coronary Heart Disease, Diabetes Mellitus, Non-Coronary Atherosclerotic Disease, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00435045
Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
Not yet reported GlaxoSmithKline 245 participants Est. completion 2007-10 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Terminated NCT NCT00437892
Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis
Not yet reported Università degli Studi dell'Insubria 10 participants Est. completion 2011-05 3 sites Stand-aloneOther conditions: Venous Thromboembolism, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00441597
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
Not yet reported Radboud University Medical Center 30 participants Est. completion 2009-03 1 siteCardiovascular disease Other conditions: Ischemia Reperfusion InjuryView official trial listing → -
Completed NCT NCT00442325
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595 participants Est. completion 2004-02 32 sitesType 2 diabetes Other conditions: Coronary Arteriosclerosis, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular DiseaseView official trial listing → -
Completed NCT NCT00442845
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2080 participants Est. completion 2004-02 121 sitesType 2 diabetes Other conditions: Coronary Arteriosclerosis, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular DiseaseView official trial listing → -
Completed NCT NCT00442897
Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)
Not yet reported Organon and Co 229 participants Est. completion 2008-10Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00446940
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
Not yet reported Bader, Ted, M.D. 16 participants Est. completion 2007-03 1 siteOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00449410
Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients
Not yet reported Radboud University Medical Center 35 participants Est. completion 2006-10 1 siteOther conditions: Atrial Fibrillation, Neuropsychology, Magnetic Resonance Imaging, Inflammation, HemostasisView official trial listing → -
Status unknown NCT NCT00452608
Statin for Immunomudulation in Sepsis
Not yet reported Hospital de Clinicas de Porto Alegre 80 participants Est. completion 2009-12 1 siteOther conditions: SepsisView official trial listing → -
Terminated NCT NCT00452842
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
Pfizer 26784 participants 1 siteCardiovascular disease Other conditions: Cerebrovascular DisordersView official trial listing → -
Completed NCT NCT00454545
Atorvastatin in Moderate Active Crohns Disease
Not yet reported Skane University Hospital 12 participants Est. completion 2007-10 1 siteOther conditions: Crohns DiseaseView official trial listing → -
Completed NCT NCT00457340
Atorvastatin For The Reduction Of Ventricular Arrhythmias
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2004-09 10 sitesOther conditions: ArrhythmiaView official trial listing → -
Completed NCT NCT00457405
Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
Not yet reported Radboud University Medical Center 10 participants Est. completion 2008-03 1 siteOther conditions: Ischemia-Reperfusion Injury, AtherosclerosisView official trial listing → -
Completed NCT NCT00458055
High-Density Lipoprotein (HDL) Treatment Study
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 19 participants Est. completion 2007-09 1 siteOther conditions: Coronary Arteriosclerosis, Hypoalphalipoproteinemias, Genetic Diseases, InbornView official trial listing → -
Completed NCT NCT00462748
A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)
Not yet reported Organon and Co 786 participants Est. completion 2008-06Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00463827
Effect of Statins on Asthma Control in Smokers With Asthma
Not yet reported NHS Greater Clyde and Glasgow 71 participants Est. completion 2009-06 1 siteOther conditions: Asthma, COPD, SmokingView official trial listing → -
Completed NCT NCT00465088
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
Not yet reported Abbott 199 participants 46 sites Stand-aloneOther conditions: Hyperlipidemia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00469326
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
Not yet reported University Hospital, Motol 200 participants Est. completion 2008-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00474240
AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia
Not yet reported Aegerion Pharmaceuticals, Inc. 157 participants Est. completion 2008-10 17 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00479388
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
Not yet reported Merck Sharp & Dohme LLC 1216 participants Est. completion 2008-10Other conditions: Primary Hypercholesterolemia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00481364
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
Not yet reported Ercan OK 446 participants Est. completion 2008-12 1 siteOther conditions: Vascular Calcification, Atherosclerosis, Dyslipidemia, InflammationView official trial listing → -
Completed NCT NCT00487994
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
Not yet reported Takeda 2130 participants Est. completion 2007-05 128 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00490698
Zoledronate With Atorvastatin in Renal Cell Carcinoma
Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: Kidney Cancer, Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT00491400
Effect of a Fibrate and a Statin on Endothelial Dysfunction
Not yet reported Boston University 28 participants Est. completion 2008-12 1 siteMetabolic syndrome Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00491530
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
Not yet reported Abbott 310 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: Mixed DyslipidemiaView official trial listing → -
Terminated NCT NCT00491751
Clinical Utility of Endothelial Dysfunction in PAD
Not yet reported Boston University 108 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT00494247
Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes
Not yet reported Silesian School of Medicine 60 participants Est. completion 2009-08 2 sitesOther conditions: Acute Coronary Syndromes, Coronary Heart DiseaseView official trial listing → -
Terminated NCT NCT00494663
A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
Not yet reported DiObex 200 participants Est. completion 2008-12 24 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00496730
A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)
Not yet reported Organon and Co 256 participants Est. completion 2008-08Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00497016
Does Statin Therapy Reduce Sympathoexcitation in Hypertension?
Not yet reported Radboud University Medical Center 13 participants Est. completion 2008-03 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00504829
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
Not yet reported Veloxis Pharmaceuticals 220 participants Est. completion 2008-07 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00505336
The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure
Not yet reported St Vincent's University Hospital, Ireland 43 participants Est. completion 2008-12 1 site Stand-aloneHeart failureView official trial listing → -
Status unknown NCT NCT00517257
Atorvastatin for the Treatment of Retinal Vein Occlusion
Not yet reported University of Toronto 180 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Retinal Vein Occlusion, Retinal Vein Thrombosis, Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion, ThrombosisView official trial listing → -
Completed NCT NCT00519363
Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Not yet reported, Not yet reported The Center for Rheumatic Disease, Allergy, & Immunology 15 participants Est. completion 2008-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT00520585
Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes
Not yet reported Masaryk University Est. completion 2007-11Other conditions: Heterogeneity of Cardiomyocytes Repolarisation, Autonomic Changes of Cardiomyocytes RepolarisationView official trial listing → -
Completed NCT NCT00522158
Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition
Not yet reported Baskent UniversityType 2 diabetesCardiovascular disease Other conditions: LDL Cholesterol, CognitionView official trial listing → -
Completed NCT NCT00529191
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Not yet reported Children's Hospital of Philadelphia 40 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00529542
A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol
Not yet reported Milton S. Hershey Medical Center 20 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00530946
A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 165 participants Est. completion 2008-04 17 sitesOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00532311
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
Not yet reported Takeda 411 participants Est. completion 2008-04 86 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00535405
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
Not yet reported Organon and Co 1289 participants Est. completion 2009-03 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00536887
Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction
Not yet reported Korea University Anam Hospital 100 participants Est. completion 2008-09 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00540293
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 425 participants Est. completion 2008-05 20 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT00541697
Eze/Simva Switch Study in Diabetics (0653A-807)
Not yet reported Organon and Co 648 participants Est. completion 2005-10-14Type 2 diabetesView official trial listing → -
Completed NCT NCT00549926
Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
Not yet reported Yokohama City University Medical Center 200 participants Est. completion 2010-02 1 siteOther conditions: Coronary Disease, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00559962
Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Not yet reported Aegerion Pharmaceuticals, Inc. 260 participants Est. completion 2008-11 15 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00570752
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
Not yet reported Bristol-Myers Squibb 72 participants Est. completion 2010-12 17 sitesOther conditions: Vascular DiseasesView official trial listing → -
Completed NCT NCT00572312
Optimalization of Nephroprotection Using Atorvastatin (Sortis)
Not yet reported Medical University of GdanskChronic kidney disease Other conditions: ProteinuriaView official trial listing → -
Completed NCT NCT00576576
Evaluation of Atorvastatin on Atherosclerosis Composition
Not yet reported Emory University 27 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00579098
The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation
Not yet reported Mayo Clinic 125 participants Est. completion 2011-12 1 siteOther conditions: Atrial Fibrillation, Arrhythmia, Inflammation, Endothelial DysfunctionView official trial listing → -
Terminated NCT NCT00579254
Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 112 participants Est. completion 2008-05Other conditions: Hypertension and Cardiovascular Risk FactorsView official trial listing → -
Terminated NCT NCT00585611
Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients
Not yet reported University of Wisconsin, Madison 1 participants Est. completion 2008-06 1 site Stand-aloneHeart failureView official trial listing → -
Withdrawn NCT NCT00587379
Effect of Chronic Statin and Viagra Therapy in Persons With Endothelial Cell Dysfunction
Not yet reported Mayo Clinic Est. completion 2008-05Other conditions: Endothelial DysfunctionView official trial listing → -
Terminated NCT NCT00590135
The Effect of Lipitor on Aortic Stenosis
Not yet reported The Cleveland Clinic 59 participants Est. completion 2010-04-26 1 site Stand-aloneOther conditions: Aortic Valve StenosisView official trial listing → -
Completed NCT NCT00603590
Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
Not yet reported Tehran University of Medical Sciences 475 participants Est. completion 2008-07 1 site Stand-aloneCardiovascular disease Other conditions: Hypertension, Hyperlipidemia, Heart DiseaseView official trial listing → -
Completed NCT NCT00609063
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
Not yet reported Hartford Hospital 420 participants Est. completion 2011-06 3 sites Stand-aloneOther conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular DiseasesView official trial listing → -
Completed NCT NCT00610545
Atorvastatin in Perioperative Vascular Surgery - Pilot Study
Not yet reported University of Campinas, Brazil 100 participants Est. completion 2008-12 1 siteOther conditions: Vascular SurgeryView official trial listing → -
Completed NCT NCT00610870
Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention
Not yet reported Samsung Medical Center 173 participants Est. completion 2009-08 1 site Stand-aloneOther conditions: Angioplasty, Transluminal, Percutaneous CoronaryView official trial listing → -
Completed NCT NCT00611143
Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery
Not yet reported Samsung Medical Center 124 participants Est. completion 2007-05 1 site Stand-aloneOther conditions: Coronary Artery BypassView official trial listing → -
Completed NCT NCT00615823
Atorvastatin in Pulmonary Hypertension
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 220 participants Est. completion 2010-05 1 siteOther conditions: Hypertension, PulmonaryView official trial listing → -
Completed NCT NCT00616187
Atorvastatin in Relapsing-Remitting Multiple Sclerosis
Not yet reported Charite University, Berlin, Germany 41 participantsOther conditions: Relapsing Remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT00616772
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Not yet reported AbbVie (prior sponsor, Abbott) 682 participants Est. completion 2012-09 124 sites Stand-aloneCardiovascular disease Other conditions: Coronary Heart Disease, DyslipidemiaView official trial listing → -
Status unknown NCT NCT00620204
Efficacy Study of Atorvastatin to Treat Variant Angina
Not yet reported Samsung Medical Center 136 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Angina Pectoris, VariantView official trial listing → -
Completed NCT NCT00620542
CRESTOR Athero Imaging Head to Head IVUS Study
Not yet reported AstraZeneca 2333 participants Est. completion 2011-06 195 sitesOther conditions: Coronary AtherosclerosisView official trial listing → -
Terminated NCT NCT00622089
Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients
Not yet reported, Not yet reported DiObex 150 participants Est. completion 2008-12 24 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00627575
AED/Statin Interaction Study
Not yet reported GlaxoSmithKline 119 participants Est. completion 2008-09-12 1 siteOther conditions: EpilepsyView official trial listing → -
Completed NCT NCT00631189
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
Not yet reported AstraZeneca 668 participants Est. completion 2008-10 170 sitesOther conditions: Type IIa and IIb HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00632840
Pharmacological Regulation of Fat Transport in Metabolic Syndrome
Not yet reported The University of Western Australia 11 participants Est. completion 2007-12Cardiovascular disease Other conditions: Obesity, Lipid Disorders, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00636766
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
Not yet reported Aristotle University Of Thessaloniki 300 participants Est. completion 2009-01 1 site Stand-aloneCardiovascular diseaseType 2 diabetesMetabolic syndrome Other conditions: Carotid AtherosclerosisView official trial listing → -
Completed NCT NCT00637481
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in SituView official trial listing → -
Completed NCT NCT00639080
Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients
Endocrine Research Society 25 participants Est. completion 2010-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00639158
Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
Not yet reported Abbott 543 participants 118 sitesOther conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed DyslipidemiaView official trial listing → -
Terminated NCT NCT00640549
Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 41 participants Est. completion 2004-10 14 sitesType 2 diabetes Other conditions: Hyperlipidemia, Non-Insulin Dependent Diabetes MellitusView official trial listing → -
Status unknown NCT NCT00640744
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
Not yet reported Baylor College of Medicine 12 participants Est. completion 2010-02 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00644670
A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 232 participants Est. completion 2004-03 17 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT00644709
A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 196 participants Est. completion 2005-03 15 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT00645151
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512 participants Est. completion 2005-02 33 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT00645424
A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 155 participants Est. completion 2004-10 5 sites Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT00647543
Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 242 participants Est. completion 2004-04 4 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT00650689
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
Not yet reported Organon and Co 122 participants Est. completion 2004-12 Stand-aloneCardiovascular disease Other conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Terminated NCT NCT00651378
Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
Not yet reported Organon and Co 87 participants Est. completion 2005-06-01 Stand-aloneCardiovascular disease Other conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00651404
Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)
Not yet reported Organon and Co 137 participants Est. completion 2004-12 Stand-aloneOther conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00652327
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
Not yet reported Organon and Co 83 participants Est. completion 2007-07 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00653588
Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks
Not yet reported AstraZeneca Est. completion 2004-09Other conditions: Hypercholesterolemia, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00653744
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
Not yet reported AstraZeneca 1700 participants Est. completion 2004-03Other conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00653796
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
Not yet reported Organon and Co 148 participants Est. completion 2004-08-01 Stand-aloneOther conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00653965
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
Not yet reported AstraZeneca 3000 participants Est. completion 2005-02Other conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00654095
Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)
Not yet reported Organon and Co 146 participants Est. completion 2009-06-01 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654173
Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)
Not yet reported AstraZeneca 4444 participants Est. completion 2004-09Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654225
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
Not yet reported AstraZeneca 2340 participants Est. completion 2005-03Other conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00654407
Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Not yet reported AstraZeneca 4875 participants Est. completion 2004-09Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00654485
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
Not yet reported AstraZeneca 940 participants Est. completion 2005-02Metabolic syndromeView official trial listing → -
Completed NCT NCT00654537
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
Not yet reported AstraZeneca 5625 participants Est. completion 2004-10Other conditions: HypercholesterolemiaView official trial listing → -
Withdrawn NCT NCT00656331
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
Not yet reported University of New Mexico Est. completion 2012-06 1 siteOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00663234
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Not yet reported, Not yet reported International Maternal Pediatric Adolescent AIDS Clinical Trials Group 28 participants Est. completion 2014-12 11 sites Stand-aloneOther conditions: HIV Infections, HyperlipidemiaView official trial listing → -
Terminated NCT NCT00664469
INdians Followed for INtensive Lipid Lowering Treatment and Its safetY
Not yet reported Sunnybrook Health Sciences Centre 64 participants Est. completion 2010-11 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00664846
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
Not yet reported Peking Union Medical College Hospital 4000 participants Est. completion 2011-04 46 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00664859
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Not yet reported, Not yet reported Veloxis Pharmaceuticals 140 participants Est. completion 2009-02 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00665834
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Not yet reported Queen's University 18 participants Est. completion 2007-09 2 sitesOther conditions: Dyslipidemia, Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT00666029
Implications for Treatment of the Metabolic Syndrome
Not yet reported University Hospital Southampton NHS Foundation Trust 40 participants Est. completion 2008-02Metabolic syndromeView official trial listing → -
Terminated NCT NCT00669695
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Not yet reported University Hospital, Grenoble 54 participants Est. completion 2013-02 4 sitesObstructive sleep apneaView official trial listing → -
Completed NCT NCT00673660
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 375 participants Est. completion 2009-10 5 sitesOther conditions: DyslipidemiaView official trial listing → -
Status unknown NCT NCT00675779
Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis
Not yet reported Poznan University of Medical Sciences 44 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: Endometriosis, PainView official trial listing → -
Completed NCT NCT00678184
The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake
Not yet reported Regional Hospital Holstebro 23 participants Est. completion 2007-10 2 sitesOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT00678522
The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes
Not yet reported Regional Hospital Holstebro 25 participants Est. completion 2008-05 2 sitesOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT00681525
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
Not yet reported Abbott 18 participants 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT00683618
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
Not yet reported AstraZeneca 934 participants Est. completion 2009-07 6 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00687076
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Not yet reported Baylor College of Medicine 102 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT00687271
A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
Not yet reported Merck Sharp & Dohme LLC 334 participants Est. completion 2009-01-08 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00689442
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Not yet reported Akros Pharma Inc. 105 participants Est. completion 2006-03 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00690443
Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia
Not yet reported Aegerion Pharmaceuticals, Inc. 44 participants Est. completion 2008-09 5 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00691314
Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis
Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2010-12 10 sites Stand-aloneCardiovascular disease Other conditions: Transient Ischemic Attack, Atherosclerosis, Stenosis, StentsView official trial listing → -
Completed NCT NCT00700037
Change in Plaque Characteristics With Atorvastatin
Not yet reported Wakayama Medical University 70 participants Est. completion 2012-02 1 site Stand-aloneOther conditions: Acute Coronary Syndrome, Atherosclerosis, DyslipidemiaView official trial listing → -
Completed NCT NCT00701220
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Not yet reported Philip Binkley 9 participants Est. completion 2010-12 1 siteCardiovascular disease Other conditions: Cardiomyopathy, Heart Disease, Myocardial Disease, Myocardial IschemiaView official trial listing → -
Completed NCT NCT00701883
Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol
Not yet reported Gilead Sciences 183 participants Est. completion 2008-08 28 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00703261
Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 83 participants Est. completion 2009-12Other conditions: Atherosclerotic Vascular DiseaseView official trial listing → -
Completed NCT NCT00715273
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
Not yet reported University of Washington 217 participants Est. completion 2019-03-01 4 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery Diseases, AtherosclerosisView official trial listing → -
Completed NCT NCT00716846
Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers
Not yet reported Hamamatsu University 11 participants Est. completion 2008-08 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT00718796
Naturopathic Treatment for the Prevention of Cardiovascular Disease
Not yet reported The Canadian College of Naturopathic Medicine 300 participants Est. completion 2009-10 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00722956
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
Not yet reported AstraZeneca 12 participants Est. completion 2008-08 1 site Stand-aloneOther conditions: Healthy Volunteers, PharmacokineticsView official trial listing → -
Status unknown NCT NCT00723320
Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
Not yet reported Ministry of Science and Technology of the People´s Republic of China 1200 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Status unknown NCT NCT00728013
China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome
Not yet reported Ministry of Science and Technology of the People´s Republic of China 1600 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00728910
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Not yet reported University of Pennsylvania 25 participants Est. completion 2009-08 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00728988
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 499 participants Est. completion 2010-04 26 sites Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00730132
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)
Organon and Co 712 participants Est. completion 2009-08Other conditions: Coronary Heart Disease, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00734123
Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
Not yet reported Hospital Arnau de Vilanova 2948 participants Est. completion 2013-05 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Status unknown NCT NCT00736463
Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)
Not yet reported Oregon Health and Science University 80 participants 1 siteOther conditions: HDL CholesterolView official trial listing → -
Completed NCT NCT00739999
8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 39 participants Est. completion 2009-05 3 sitesOther conditions: Pediatric Heterozygous HypercholesterolemiaView official trial listing → -
Completed NCT NCT00741078
Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00741715
Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Not yet reported Sanofi 1736 participants Est. completion 2009-06 2 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00743925
FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Not yet reported Anthera Pharmaceuticals 625 participants Est. completion 2010-04 44 sitesOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00745836
Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients
Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00751907
Cerebral and Peripheral Perfusion Pilot Study
Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2007-04 1 site Stand-aloneOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00754507
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.
Not yet reported Daiichi Sankyo 65 participants Est. completion 2005-04 13 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00756886
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Not yet reported University of Alabama at Birmingham 73 participants Est. completion 2011-05 1 siteOther conditions: ArrhythmiaView official trial listing → -
Completed NCT NCT00758004
Bioequivalence Study Of Pediatric Appropriate Formulation
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2009-03 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00760786
Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque
Not yet reported Samsung Medical Center 60 participants 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT00767130
DNA Diagnostic System for Statin Safety and Efficacy
Genomas, Inc 750 participants Est. completion 2009-12 3 sitesOther conditions: Hypercholesterolemia, MyopathyView official trial listing → -
Terminated NCT NCT00767572
Statins and Endothelial Function in Patients With Coarctation of the Aorta
Not yet reported University of California, San Francisco 12 participants Est. completion 2010-07 1 site Stand-aloneOther conditions: Coarctation of the AortaView official trial listing → -
Completed NCT NCT00768638
Study of Atorvastatin Dose Dependent Reduction of Proteinuria
Not yet reported Laval University 23 participants Est. completion 2014-06 1 siteChronic kidney diseaseView official trial listing → -
Completed NCT NCT00770575
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
Not yet reported Takeda 148 participants Est. completion 2006-10 Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00770679
Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging
Not yet reported Johns Hopkins University 16 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00770796
Statins for Prevention of Contrast Induced Nephropathy
Not yet reported Ospedale Misericordia e Dolce 304 participants Est. completion 2008-03Other conditions: Contrast Induced NephropathyView official trial listing → -
Completed NCT NCT00772564
The Use of Statins for Myocardial Death Prevention
Not yet reported Rambam Health Care Campus 25 participants Est. completion 2010-08 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00777517
Bioequivalence Study On Pediatric Appropriate Formulation
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2009-02 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00782184
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
Not yet reported Organon and Co 250 participants Est. completion 2010-09 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00791648
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Not yet reported Vanderbilt University Medical Center 653 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Acute Kidney Injury, Post-Operative Delirium, Icu Delirium, Acute Renal Failure, DeliriumView official trial listing → -
Completed NCT NCT00793754
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
Not yet reported Fundacion GESICA 30 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00795912
A Study Of The Usage Of Statins In A Community Heart Failure Population
Not yet reported St Vincent's University Hospital, Ireland 56 participants Est. completion 2008-01 1 siteHeart failureView official trial listing → -
Completed NCT NCT00804843
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 100 participants Est. completion 2010-10 Stand-aloneOther conditions: Carotid AtherosclerosisView official trial listing → -
Terminated NCT NCT00805311
Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis
Not yet reported Russian Cardiology Research and Production Center 400 participants Est. completion 2014-05 2 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery Stenosis, AtherosclerosisView official trial listing → -
Completed NCT NCT00808717
Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)
Not yet reported Yonsei University 170 participants 1 site Stand-aloneCardiovascular disease Other conditions: Angioplasty, Percutaneous CoronaryView official trial listing → -
Status unknown NCT NCT00811330
Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis
Not yet reported University Hospital, Strasbourg, France 60 participants Est. completion 2018-01 1 site Stand-aloneOther conditions: Aortic Valve Stenosis, Ventricular HypertrophyView official trial listing → -
Completed NCT NCT00814255
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
Not yet reported NYU Langone Health 32 participants Est. completion 2014-02 18 sitesOther conditions: Focal Segmental GlomerulosclerosisView official trial listing → -
Completed NCT NCT00816244
Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer
Not yet reported Lund University Hospital 50 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: Breast Cancer, PostmenopausalView official trial listing → -
Status unknown NCT NCT00818103
Characteristic Study on Chinese Patients With Multiple Sclerosis
Not yet reported Sun Yat-sen University 600 participants Est. completion 2016-01 1 site Stand-aloneOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00827606
Atorvastatin Three Year Pediatric Study
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 272 participants Est. completion 2013-10 40 sites Stand-aloneOther conditions: Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT00844376
Bioavailability Study for New Atorvastatin Formulation
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 12 participants Est. completion 2008-03 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00844402
Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
Not yet reported Medical University of Graz 40 participants Est. completion 2007-11 1 site Stand-aloneOther conditions: Primary Biliary Cirrhosis, HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00850460
Quality of Life in Patients With Statin-Associated Myopathy
Not yet reported Rockefeller University 14 participants Est. completion 2013-02 1 siteOther conditions: Statin Adverse ReactionView official trial listing → -
Completed NCT NCT00861861
Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)
Not yet reported Kumamoto University 129 participants Est. completion 2013-10 1 siteCardiovascular disease Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00862251
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
Not yet reported Organon and Co 808 participants Est. completion 2011-03 Stand-aloneOther conditions: Cardiovascular Disorder, Diabetes MellitusView official trial listing → -
Completed NCT NCT00864643
Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia
Not yet reported Takeda 172 participants Est. completion 2005-02 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00868127
Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia
Not yet reported Takeda 574 participants Est. completion 2007-07 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00871351
Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)
Not yet reported Organon and Co 125 participants Est. completion 2010-05-01 Stand-aloneOther conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT00889226
Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia
Not yet reported JW Pharmaceutical 161 participants Est. completion 2010-01Other conditions: Hypercholesterolemia With Type2DMView official trial listing → -
Status unknown NCT NCT00902967
Study To Check The Analgesic And Anti-Inflammatory Effects Of Atorvastatin In Patients Undergoing Abdominal Surgery
Not yet reported B. J. Medical College, Pune 40 participants Est. completion 2010-02 1 siteOther conditions: Abdominal SurgeryView official trial listing → -
Completed NCT NCT00910221
Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial
Not yet reported, Not yet reported Austin Health 100 participants Est. completion 2011-09 1 siteOther conditions: Acute Kidney DysfunctionView official trial listing → -
Terminated NCT NCT00911339
Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 13 participants Est. completion 2021-05-13 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT00914017
Statins and Breast Cancer Biomarkers
Not yet reported University of Vermont 100 participants 7 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00917527
Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease
Not yet reported Yonsei University 77 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00917579
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00917644
Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00920101
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
Not yet reported National Defense Medical College, Japan 30 participants Est. completion 2013-12 1 siteOther conditions: Atherosclerosis, InflammationView official trial listing → -
Completed NCT NCT00926614
Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba
Not yet reported Brooke Army Medical Center 20 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Hepatitis cView official trial listing → -
Completed NCT NCT00930670
Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects
Not yet reported Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 320 participants Est. completion 2011-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT00932048
Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
Not yet reported Korea University Est. completion 2012-03 1 site Stand-aloneType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00942591
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
Not yet reported Insel Gruppe AG, University Hospital Bern 77 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00944827
Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia
Not yet reported University of Thessaly 40 participants Est. completion 2009-10 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00952770
Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty
Not yet reported Chungnam National University 140 participants 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00960323
Drug-Drug Interaction Study Between Colchicine and Atorvastatin
Not yet reported Mutual Pharmaceutical Company, Inc. 24 participants Est. completion 2009-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00965055
Ezetimibe in Patients Hypo-responsive to Statins
Not yet reported University of California, San Diego 2 participants Est. completion 2012-09 1 site Stand-aloneCardiovascular disease Other conditions: High CholesterolView official trial listing → -
Completed NCT NCT00965185
Statin Therapy to Improve Atherosclerosis in HIV Patients
Not yet reported Massachusetts General Hospital 40 participants Est. completion 2014-01 1 site Stand-aloneCardiovascular disease Other conditions: HIV, Atherosclerosis, Inflammation, Statins, HMG-CoA, HIV InfectionsView official trial listing → -
Completed NCT NCT00967252
Impact of Chronic Statin Use During Surgery on Inflammation and Infection Rates
Ottawa Hospital Research Institute 50 participants Est. completion 2011-07 1 siteOther conditions: Inflammation, Infection, Endothelial FunctionView official trial listing → -
Completed NCT NCT00967434
Statin Drugs to Prevent Complications During Surgery
Not yet reported Ottawa Hospital Research Institute 60 participants Est. completion 2010-12 1 siteCardiovascular disease Other conditions: Inflammation, Myocardial IschemiaView official trial listing → -
Withdrawn NCT NCT00973271
Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Not yet reported Essentialis, Inc. Est. completion 2011-12 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00973986
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
Not yet reported Liuhuaqiao Hospital 20 participants Est. completion 2011-03 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Terminated NCT NCT00974740
DIATOR-Diabetes Intervention With Atorvastatin
Not yet reported Profil Institut für Stoffwechselforschung GmbH 63 participants Est. completion 2009-03 12 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00977288
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
Not yet reported Merck Sharp & Dohme LLC 408 participants Est. completion 2014-04 Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00979758
Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 100 participants Est. completion 2016-06 1 site Stand-aloneCardiovascular disease Other conditions: Stem Cell Transplantation, Angioplasty, Transluminal, Percutaneous CoronaryView official trial listing → -
Terminated NCT NCT00979940
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
Not yet reported Indiana University 60 participants Est. completion 2014-08 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00986583
Effect of Succinylcholine on Patients Using Statins
Not yet reported The Cleveland Clinic 70 participants Est. completion 2010-07 1 siteOther conditions: PainView official trial listing → -
Completed NCT NCT00987974
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
Not yet reported Radboud University Medical Center 48 participants Est. completion 2010-03 1 siteOther conditions: Ischemia Reperfusion Injury, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT00990808
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2011-07 Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00991705
A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Not yet reported Boryung Pharmaceutical Co., Ltd 28 participants Est. completion 2009-09Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00993915
Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 687 participants Est. completion 2011-12Cardiovascular diseaseView official trial listing → -
Completed NCT NCT01004406
Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I
Not yet reported VA Office of Research and Development 59 participants Est. completion 2013-03 2 sites Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01013103
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
Not yet reported Hippocration General Hospital 72 participants Est. completion 2012-02 1 siteCardiovascular disease Other conditions: HMG-CoA Reductase Inhibitor Toxicity, Atherosclerosis, Oxidative Stress, Endothelial DysfunctionView official trial listing → -
Terminated NCT NCT01013870
Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol
Not yet reported Baylor College of Medicine 52 participants Est. completion 2015-06 2 sites Stand-aloneOther conditions: Traumatic Brain Injury, Post-traumatic Stress DisorderView official trial listing → -
Completed NCT NCT01015144
The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
Medical University of Lodz Est. completion 2009-02Other conditions: Dilated CardiomyopathyView official trial listing → -
Completed NCT NCT01023607
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
Not yet reported Harbin Medical University 120 participants Est. completion 2013-08 1 site Stand-aloneCardiovascular disease Other conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT01029522
Dyslipidemia in Cardiovascular Disease
Not yet reported Chong Kun Dang Pharmaceutical 244 participants Est. completion 2009-11 Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Withdrawn NCT NCT01030328
AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
Not yet reported Piedmont Healthcare Est. completion 2011-07 1 siteOther conditions: Coronary AtherosclerosisView official trial listing → -
Status unknown NCT NCT01033058
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
Not yet reported Beijing Chao Yang Hospital 500 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: STEMIView official trial listing → -
Status unknown NCT NCT01040936
Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Not yet reported Shanghai Jiao Tong University School of Medicine 300 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01041729
Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
Not yet reported Hospital Universitario Getafe 60 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT01043380
Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound
Not yet reported Kumamoto University 245 participants Est. completion 2014-09 1 site Stand-aloneCardiovascular disease Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01047501
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01047683
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01050348
To Investigate the Role of Upstream High Dose Statin in STEMI
Not yet reported The Western Pennsylvania Hospital 120 participants Est. completion 2010-06 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01053065
The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study
Not yet reported University of Padova 60 participants 3 sitesOther conditions: Symptomatic Carotid Stenosis, Hypercholesterolemia, Indication for Carotid EndarterectomyView official trial listing → -
Status unknown NCT NCT01058057
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
Not yet reported University Hospital, Motol 200 participants 1 site Stand-aloneCardiovascular disease Other conditions: Coronary AngioplastyView official trial listing → -
Completed NCT NCT01059864
Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550
Not yet reported Pfizer 111 participants Est. completion 2010-11 15 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01062802
Statin Use in Abdominal Aortic Aneurysm Repair
Not yet reported University of Hull 40 participants Est. completion 2008-12 1 siteOther conditions: Abdominal Aortic AneurysmView official trial listing → -
Status unknown NCT NCT01063426
Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users
Not yet reported Hallym University Medical Center 180 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: Thrombosis, Prevention, SurgeryView official trial listing → -
Terminated NCT NCT01071993
Efficacy of Statins In Prevention of CIN
Not yet reported University of Oklahoma 21 participants Est. completion 2013-07 2 sitesOther conditions: NephropathyView official trial listing → -
Completed NCT NCT01072097
The Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) Women
Not yet reported University of Oulu 30 participants Est. completion 2011-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01073800
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
Not yet reported, Not yet reported University of Alberta 100 participants Est. completion 2011-09 1 siteCardiovascular disease Other conditions: Renal FailureView official trial listing → -
Completed NCT NCT01078285
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2011-11 3 sitesOther conditions: Medication Non-AdherenceView official trial listing → -
Completed NCT NCT01081548
A Clinical Trial Study to Evaluate Efficacy and Safety of Atorvastatin in Korean Patients With Hypercholesterolemia
Not yet reported Yonsei University 17 participants Est. completion 2009-07 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01086020
Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2012-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01096875
Effects of Atorvastatin on Endothelial Progenitor Cells After Coronary Surgery
Not yet reported Ankara University 60 participants Est. completion 2010-10 1 siteOther conditions: Coronary Artery Bypass Surgery, Elective Surgical ProcedureView official trial listing → -
Completed NCT NCT01099176
Effects of Hypolipemic Treatment on Adipokines
Not yet reported Medical University of Silesia 78 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Hyperlipidemia, Impaired Fasting GlycemiaView official trial listing → -
Completed NCT NCT01105975
A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
Not yet reported Eli Lilly and Company 398 participants Est. completion 2011-06 59 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01107743
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1291 participants Est. completion 2012-04Other conditions: Hypertension, Angina Pectoris, Hypercholesterolemia, Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT01111656
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
Not yet reported Insel Gruppe AG, University Hospital Bern 28 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: Relapsing-remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT01112670
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
Not yet reported University of Colorado, Denver 33 participants Est. completion 2011-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01115985
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: Healthy, Pharmacokinetics of AtorvastatinView official trial listing → -
Completed NCT NCT01126684
Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion
Not yet reported Aristotle University Of Thessaloniki 50 participants 1 siteOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01127945
Study to Evaluate the Effectiveness of High Dose Statin Loading in Acute Heart Failure Patients
Not yet reported Yonsei University 50 participants Est. completion 2013-11 1 site Stand-aloneHeart failureView official trial listing → -
Terminated NCT NCT01130246
VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Not yet reported Anthera Pharmaceuticals 5189 participants Est. completion 2012-03 362 sites Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01138072
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Not yet reported GlaxoSmithKline 14 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT01154036
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
Not yet reported Organon and Co 1547 participants Est. completion 2012-10 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01161082
Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin
Not yet reported Regeneron Pharmaceuticals 72 participants Est. completion 2011-05 2 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01163851
Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin
Not yet reported Pfizer 25 participants Est. completion 2011-04 5 sitesOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT01166633
Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia
Not yet reported JW Pharmaceutical 200 participants Est. completion 2011-02Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01175148
Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation
Not yet reported West Virginia University 60 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Graft vs Host DiseaseView official trial listing → -
Status unknown NCT NCT01185236
Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes
Not yet reported Seoul National University Hospital 132 participants Est. completion 2011-08 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01186289
Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
Not yet reported Duke University Est. completion 2012-10 1 site Stand-aloneOther conditions: Neurocognitive DysfunctionView official trial listing → -
Terminated NCT NCT01187992
Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease
Not yet reported San Filippo Neri General Hospital 290 participants Est. completion 2007-04 1 site Stand-aloneCardiovascular disease Other conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01190007
Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 159 participants Est. completion 2012-02 20 sitesOther conditions: Hypertension, Hypercholesterolemia, Angina PectorisView official trial listing → -
Completed NCT NCT01200056
Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
Not yet reported Prof. Stephen Lee 40 participants Est. completion 2010-06 1 siteOther conditions: Coronary Disease, Ultrasonography, Interventional, Hydroxymethylglutaryl-CoA Reductase InhibitorsView official trial listing → -
Completed NCT NCT01208701
The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy
Not yet reported Erling Bjerregaard Pedersen 25 participants Est. completion 2012-01 1 siteCardiovascular disease Other conditions: Nephropathy, Diabetes MellitusView official trial listing → -
Completed NCT NCT01213498
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
Not yet reported Erling Bjerregaard Pedersen 25 participants Est. completion 2012-01 1 siteCardiovascular disease Other conditions: NephropathyView official trial listing → -
Completed NCT NCT01214746
The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man
Not yet reported Regional Hospital Holstebro 26 participants Est. completion 2011-06 1 siteCardiovascular disease Other conditions: NephropathyView official trial listing → -
Completed NCT NCT01218204
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
Not yet reported GlaxoSmithKline 287 participants Est. completion 2011-06-29 21 sites Stand-aloneOther conditions: Dyslipidaemias, DyslipidemiasView official trial listing → -
Completed NCT NCT01220973
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Not yet reported Rutgers, The State University of New Jersey 27 participants Est. completion 2014-11-18 4 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01222182
Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)
Mayo Clinic 260 participants Est. completion 2011-06 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01223586
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
Kyoto University 238 participants Est. completion 2011-05 2 sitesOther conditions: Statin, Coronary Plaque, Acute Coronary Syndrome, Intravascular Ultrasound, Cardiovascular EventsView official trial listing → -
Completed NCT NCT01228227
ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading
Not yet reported Gennaro Sardella 310 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Assess the Periprocedural Myocardial NecrosisView official trial listing → -
Completed NCT NCT01236365
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Not yet reported Nemours Children's Clinic 42 participants Est. completion 2014-11 5 sites Stand-aloneOther conditions: Diabetes Mellitus, Insulin-Dependent, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01236430
A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)
Not yet reported Organon and Co 200 participants Est. completion 2012-02 Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Status unknown NCT NCT01239849
Korean AMADEUS Study
Not yet reported The Catholic University of Korea 500 participants Est. completion 2011-02 1 siteOther conditions: Diabetes Mellitus, HypercholessterolemiaView official trial listing → -
Completed NCT NCT01245608
Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
Not yet reported Tehran University of Medical Sciences 2400 participants Est. completion 2018-09 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01250834
LY2189265 and Atorvastatin Interaction Study
Not yet reported Eli Lilly and Company 27 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01255852
Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
Not yet reported Jinling Hospital, China 100 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: CVDView official trial listing → -
Completed NCT NCT01257009
Atorvastatin and Sympathetic Activity in Chronic Kidney Disease
Not yet reported UMC Utrecht 10 participants Est. completion 2010-07 1 siteChronic kidney disease Other conditions: HypertensionView official trial listing → -
Terminated NCT NCT01259284
Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer
Not yet reported, Not yet reported M.D. Anderson Cancer Center 2 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Advanced CancersView official trial listing → -
Completed NCT NCT01259791
Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Statin MyopathyView official trial listing → -
Completed NCT NCT01263938
Modulation of Monocyte Activation by Atorvastatin in HIV Infection
Not yet reported University of Pennsylvania 5 participants Est. completion 2017-10 1 siteOther conditions: HIV DementiaView official trial listing → -
Completed NCT NCT01271985
Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill
Not yet reported Tehran University of Medical Sciences 8410 participants Est. completion 2019-01 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01278459
Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia?
Not yet reported University of Oxford 11 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: Pre-EclampsiaView official trial listing → -
Completed NCT NCT01279590
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
Not yet reported Furiex Pharmaceuticals, Inc 282 participants Est. completion 2011-11 67 sitesOther conditions: Myalgia, Hypercholesterolemia, HyperlipidemiaView official trial listing → -
Completed NCT NCT01285544
The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
Not yet reported Seoul National University Hospital 289 participants Est. completion 2009-07 1 site Stand-aloneCardiovascular disease Other conditions: Dyslipidemia, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01288443
Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy
Not yet reported Sanofi 183 participants Est. completion 2011-12 38 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01288469
Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia
Not yet reported Sanofi 92 participants Est. completion 2011-09 20 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01293097
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
Not yet reported Peking University First Hospital 2884 participants Est. completion 2011-10 1 siteCardiovascular disease Other conditions: Unstable Angina Pectoris, Stable Angina PectorisView official trial listing → -
Completed NCT NCT01299181
A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
Not yet reported University of Edinburgh 60 participants Est. completion 2013-08 1 siteOther conditions: BronchiectasisView official trial listing → -
Completed NCT NCT01299194
Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa
Not yet reported University of Edinburgh 32 participants Est. completion 2017-05 1 siteOther conditions: BRONCHIECTASISView official trial listing → -
Completed NCT NCT01299597
A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.
Not yet reported GlaxoSmithKline 30 participants Est. completion 2010-02-26 1 site Stand-aloneOther conditions: Sleep DisordersView official trial listing → -
Completed NCT NCT01304641
Cardiovascular Events Based On Statin Initiation In The Elderly
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 31603 participants Est. completion 2011-02Other conditions: Cardiovascular, DyslipidemiaView official trial listing → -
Completed NCT NCT01305317
Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
Not yet reported Hormozgan University of Medical Sciences 74 participants Est. completion 2010-01 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT01306565
High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)
Not yet reported Hormozgan University of Medical Sciences 100 participants Est. completion 2011-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01318564
Diabetic Treatment Adherence
M.D. Anderson Cancer Center 28 participants Est. completion 2016-08 2 sitesOther conditions: Endocrine System DiseasesView official trial listing → -
Status unknown NCT NCT01322711
Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
Not yet reported University of Roma La Sapienza 60 participants Est. completion 2015-12 1 siteType 2 diabetes Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01332747
Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation
Not yet reported Jamia Hamdard University 128 participants Est. completion 2011-05 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Status unknown NCT NCT01334671
The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI
Not yet reported General Hospital of Chinese Armed Police Forces 150 participants Est. completion 2013-03 1 site Stand-aloneCardiovascular disease Other conditions: (STEMI)View official trial listing → -
Completed NCT NCT01335048
Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity
Not yet reported Ospedale Misericordia e Dolce 50 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: Stable AnginaView official trial listing → -
Terminated NCT NCT01341730
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
Not yet reported The Catholic University of Korea 41 participants Est. completion 2012-08 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01342211
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
Not yet reported Pfizer 93 participants Est. completion 2012-06 44 sites Stand-aloneOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT01350141
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
Not yet reported Pfizer 46 participants Est. completion 2012-06 35 sitesOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT01351025
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 98 participants Est. completion 2014-05 31 sites Stand-aloneOther conditions: HIV-1 InfectionView official trial listing → -
Completed NCT NCT01352897
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
AstraZeneca 800 participants Est. completion 2010-12 1 siteOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01363999
A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers
Not yet reported Hoffmann-La Roche 24 participants Est. completion 2011-07 1 site Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT01370590
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
Not yet reported Organon and Co 406 participants Est. completion 2012-04 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01370603
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
Not yet reported Organon and Co 328 participants Est. completion 2012-05 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01372839
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
Not yet reported Xijing Hospital 300 participants 1 siteCardiovascular disease Other conditions: Unstable AnginaView official trial listing → -
Completed NCT NCT01375075
A Study of LY2484595 in Japanese Subjects
Not yet reported Eli Lilly and Company 165 participants Est. completion 2012-03 5 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT01385631
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
Not yet reported Odense University Hospital 87 participants Est. completion 2014-09 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01386853
Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Not yet reported Tai Tien Pharmaceuticals Co., Ltd. 200 participants Est. completion 2012-07 6 sitesOther conditions: HyperlipidemiaView official trial listing → -
Terminated NCT NCT01394848
Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy
Not yet reported Yonsei University 1 participants Est. completion 2013-01 1 siteOther conditions: Stable AnginaView official trial listing → -
Completed NCT NCT01431105
Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities
Not yet reported, Not yet reported University of California, San Diego 34 participants Est. completion 2018-07 1 site Stand-aloneOther conditions: Kawasaki DiseaseView official trial listing → -
Withdrawn NCT NCT01442428
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Not yet reported, Not yet reported University of Minnesota Est. completion 2016-06 3 sites Stand-aloneOther conditions: Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome, Tuberculosis, HIV-infection/AidsView official trial listing → -
Completed NCT NCT01442987
Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
Not yet reported Hanmi Pharmaceutical Company Limited 230 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01446679
Special Drug Use-Results Survey of Lipitor Tablets
Astellas Pharma Inc 24050 participants Est. completion 2012-03 8 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01447797
A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
Not yet reported Hanmi Pharmaceutical Company Limited 52 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01448174
Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
Not yet reported Poznan University of Medical Sciences 310 participants Est. completion 2014-10 1 siteMetabolic syndromeType 2 diabetes Other conditions: Renal Failure Chronic Requiring Hemodialysis, HyperlipidemiaView official trial listing → -
Completed NCT NCT01448642
Statins Evaluation in Coronary Procedures and Revascularization Trial
Not yet reported Hospital do Coracao 4191 participants Est. completion 2018-04 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT01455935
Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Not yet reported Jacobs Neurological Institute 90 participants Est. completion 2014-02 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01477853
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Not yet reported Merck Sharp & Dohme LLC 166 participants Est. completion 2012-12-04 Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01491256
Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin Loading
Not yet reported The Korean Society of Circulation 100 participants Est. completion 2012-02 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01491958
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2016-06-27 1 site Stand-aloneOther conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01492361
A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01495013
A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
Not yet reported GlaxoSmithKline 427 participants Est. completion 2013-09 33 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01497912
Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes
Not yet reported Karolinska Institutet 20 participants Est. completion 2010-01 1 siteOther conditions: Type 1 Diabetes Mellitus, DyslipidemiaView official trial listing → -
Completed NCT NCT01499758
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
Not yet reported Ranbaxy Laboratories Limited 80 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01499771
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions
Not yet reported Ranbaxy Laboratories Limited 80 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01502943
Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index
Not yet reported Liaoning University of Traditional Chinese Medicine 480 participants Est. completion 2011-12 10 sites Stand-aloneOther conditions: Coronary Heart Disease, Stable Angina PectorisView official trial listing → -
Status unknown NCT NCT01503671
Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients
Not yet reported National Taiwan University Hospital 36 participants Est. completion 2015-10 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01507831
Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)
Not yet reported Sanofi 2341 participants Est. completion 2014-11 320 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01516879
Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study
Not yet reported Amgen 905 participants Est. completion 2013-10-14 96 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01518166
Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
Not yet reported Novo Nordisk A/S 70 participants Est. completion 2007-04 1 site Added to GLP-1Other conditions: Diabetes, HealthyView official trial listing → -
Status unknown NCT NCT01518231
Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
Not yet reported Zhejiang Hospital 40 participants Est. completion 2013-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01525407
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Not yet reported Fred Hutchinson Cancer Center 83 participants Est. completion 2016-02 3 sites Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Completed NCT NCT01526460
Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention
Not yet reported IRCCS San Raffaele 146 participants Est. completion 2014-02 1 siteOther conditions: Platelet DysfunctionView official trial listing → -
Completed NCT NCT01527045
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Not yet reported Fred Hutchinson Cancer Center 47 participants Est. completion 2019-04 2 sites Stand-aloneOther conditions: Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia, Loss of Chromosome 17p, Myelodysplastic/Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Aggressive Adult Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Waldenstrom MacroglobulinemiaView official trial listing → -
Withdrawn NCT NCT01527097
Influence of Atorvastatin on Psoriasis Severity and Endothelial Function
Not yet reported shmuel fuchs Est. completion 2015-04 1 site Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01528709
Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)
Not yet reported Boca Raton Regional Hospital 173 participants Est. completion 2017-01 2 sites Stand-aloneOther conditions: Saphenous Vein Graft DiseaseView official trial listing → -
Completed NCT NCT01541943
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
Not yet reported HanAll BioPharma Co., Ltd. 356 participants Est. completion 2014-11 1 siteOther conditions: Essential Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01543555
Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose
Not yet reported Hospital do Coracao 648 participants Est. completion 2015-06 1 site Stand-aloneCardiovascular disease Other conditions: Peripheral Vascular Disease, Aortic AneurismView official trial listing → -
Completed NCT NCT01544309
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
Not yet reported Listen Trial Group 1049 participants 133 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01544751
Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin
Not yet reported Prof Antonino Belfiore 150 participants Est. completion 2015-06 1 siteMASLDView official trial listing → -
Completed NCT NCT01547455
Safety and Efficiency Study of Loading Dose Atorvastatin in Cardiac Surgery
Not yet reported Peking Union Medical College 96 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Acute Kidney InjuryView official trial listing → -
Status unknown NCT NCT01548326
Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine
Not yet reported Nematollah Jonaidi Jafari 52 participants Est. completion 2012-07 1 siteOther conditions: Hepatitis B, Vaccination FailureView official trial listing → -
Status unknown NCT NCT01550419
Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
Not yet reported Shanghai Minhang Central Hospital 100 participants Est. completion 2014-02 1 site Stand-aloneCardiovascular disease Other conditions: Ventilator-associated PneumoniaView official trial listing → -
Withdrawn NCT NCT01555632
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
Not yet reported University of Nebraska Est. completion 2013-02 Stand-aloneOther conditions: Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Status unknown NCT NCT01557075
Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation
Not yet reported Yonsei University 2000 participants Est. completion 2015-08 1 siteOther conditions: Drug-eluting Stent (DES)View official trial listing → -
Status unknown NCT NCT01558245
Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis
Not yet reported Jinling Hospital, China 99 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Cerebrovascular DiseaseView official trial listing → -
Completed NCT NCT01563731
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
Not yet reported Istituto Auxologico Italiano 200 participants Est. completion 2021-03-31 1 siteCardiovascular disease Other conditions: Transient Ischemic Attack, HypertensionView official trial listing → -
Status unknown NCT NCT01567774
Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-06 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01567826
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Not yet reported Annapoorna Kini 87 participants Est. completion 2012-02 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01569100
Atorvastatin After Aneurysmal Subarachnoid Hemorrhage
Groupe Hospitalier Pitie-Salpetriere 278 participants Est. completion 2007-12Other conditions: SAHView official trial listing → -
Withdrawn NCT NCT01569854
Genetic Influence on Statin Pharmacodynamics
Ohio State University Est. completion 2022-03 1 siteOther conditions: Hyperlipidemia, Hypercholesterolemia, DyslipidemiaView official trial listing → -
Terminated NCT NCT01570530
Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery
Not yet reported Fundación General Universidad de Valladolid 90 participants Est. completion 2014-09 1 siteOther conditions: Atrial FibrillationView official trial listing → -
Status unknown NCT NCT01572623
Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Not yet reported Campus Bio-Medico University 150 participants Est. completion 2012-09 1 siteOther conditions: Carotid StenosisView official trial listing → -
Completed NCT NCT01581476
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Not yet reported University of Cambridge 443 participants Est. completion 2017-06 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01588795
Renal Denervation in Diabetic Nephropathy
Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2016-01 1 siteChronic kidney disease Other conditions: Persistent Proteinuria With Type II DiabetesView official trial listing → -
Completed NCT NCT01600170
Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
Not yet reported University of Pennsylvania 11 participants Est. completion 2017-10 1 siteOther conditions: HIV DementiaView official trial listing → -
Withdrawn NCT NCT01605344
Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2014-07 1 site Stand-aloneOther conditions: Advanced Adenocarcinoma of the Colon or RectumView official trial listing → -
Status unknown NCT NCT01617538
Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis
Not yet reported, Not yet reported Capital Medical University 30 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: StenosisView official trial listing → -
Completed NCT NCT01617655
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)
Not yet reported Sanofi 107 participants Est. completion 2015-01 35 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Status unknown NCT NCT01617772
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
Not yet reported Tehran University of Medical Sciences 440 participants Est. completion 2019-12 2 sites Stand-aloneOther conditions: Non-alcoholic SteatohepatitisView official trial listing → -
Completed NCT NCT01623115
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Not yet reported Sanofi 486 participants Est. completion 2014-12 91 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01624207
The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg
Not yet reported Seoul National University Hospital 376 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01633359
The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients
Not yet reported Ji Huang 300 participants Est. completion 2013-05 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01634906
Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
Not yet reported Sint Franciscus Gasthuis 55 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Hyperlipidemia, AtherosclerosisView official trial listing → -
Completed NCT NCT01635946
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin
Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Atorvastatin, Healthy VolunteersView official trial listing → -
Completed NCT NCT01644175
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
Not yet reported Sanofi 316 participants Est. completion 2014-04 76 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01644188
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)
Not yet reported Sanofi 720 participants Est. completion 2015-07 126 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01645176
Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
Not yet reported Stanford University 21 participants Est. completion 2016-10 1 site Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT01645384
Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 69 participants Est. completion 2009-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01645410
Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 71 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01645423
Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 77 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01645449
Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 77 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01646307
Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI
Not yet reported Beijing Anzhen Hospital 1000 participants Est. completion 2013-06 1 siteOther conditions: Focus of StudyView official trial listing → -
Status unknown NCT NCT01648829
PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2017-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01660191
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
Not yet reported University of Kansas Medical Center 134 participants Est. completion 2013-10 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01663402
ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Not yet reported Sanofi 18924 participants Est. completion 2018-01-23 1388 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01665235
Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis
Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Blood Pressure Variability, Intracranial Artery StenosisView official trial listing → -
Completed NCT NCT01665677
Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
Not yet reported Mehdi Hamadani 69 participants Est. completion 2021-07-09 2 sites Stand-aloneOther conditions: Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT01673178
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Not yet reported Pfizer 107 participants Est. completion 2013-09 17 sitesOther conditions: Diabetes Melliuts, Type 2View official trial listing → -
Status unknown NCT NCT01674686
The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
Not yet reported Samsung Medical Center 200 participants Est. completion 2018-12-31 1 site Stand-aloneOther conditions: Variant AnginaView official trial listing → -
Completed NCT NCT01686230
Acupuncture in Patients With Stable Angina Pectoris
Not yet reported Chengdu University of Traditional Chinese Medicine 404 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Angina, StableView official trial listing → -
Completed NCT NCT01689623
A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants
Not yet reported Janssen Research & Development, LLC 36 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT01692717
Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide
Not yet reported Azidus Brasil 90 participants Est. completion 2013-05-31 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Terminated NCT NCT01697735
The Therapeutic Effects of Statins and Berberine on the Hyperlipemia
Not yet reported Wenzhou Medical University 24 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT01700075
Physical and Chemical Study of Atherosclerosis Mechanisms
Not yet reported Nazarbayev University 97 participants Est. completion 2011-12 1 siteCardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis of Femoral ArteryView official trial listing → -
Completed NCT NCT01702987
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
Not yet reported Beth Israel Deaconess Medical Center 22 participants Est. completion 2013-10 1 siteOther conditions: Myopathy, HMG COA Reductase Inhibitor Adverse Reaction, HypercholesterolemiaView official trial listing → -
Completed NCT NCT01709500
Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
Not yet reported Regeneron Pharmaceuticals 249 participants Est. completion 2015-01 24 sites Stand-aloneOther conditions: Heterozygous Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT01709513
Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
Not yet reported Regeneron Pharmaceuticals 314 participants Est. completion 2017-05-31 70 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01710007
Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
Not yet reported Orient Pharma Co., Ltd. 202 participants Est. completion 2012-11 8 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01715714
Statin Recapture Therapy Before Coronary Artery Bypass Grafting
Not yet reported University of Cologne 2630 participants Est. completion 2020-09-27 10 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01720719
Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
Not yet reported Xin Gao 120 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Fatty Liver, Dyslipidemias, Diabetes MellitusView official trial listing → -
Completed NCT NCT01730040
Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)
Not yet reported Regeneron Pharmaceuticals 355 participants Est. completion 2014-05 97 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01732718
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
Not yet reported University of North Carolina, Chapel Hill 13 participants Est. completion 2018-01-09 1 site Stand-aloneOther conditions: Sickle Cell Disease, Sickle Cell NephropathyView official trial listing → -
Completed NCT NCT01733953
Statin Therapy in Young Adult Survivors of Childhood Cancer
Not yet reported University of Minnesota 27 participants Est. completion 2016-03 1 site Stand-aloneCardiovascular disease Other conditions: Childhood ALL, Childhood NHLView official trial listing → -
Completed NCT NCT01748279
The Effects of Atorvastatin Treatment in COPD Patients
Not yet reported Medical University of Bialystok 18 participants Est. completion 2013-04 1 siteOther conditions: COPDView official trial listing → -
Status unknown NCT NCT01751295
Statin and Post-interventional Coronary Microcirculation Dysfunction
Not yet reported Samsung Medical Center 84 participants Est. completion 2014-08 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01759836
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer
Not yet reported Asan Medical Center 364 participants Est. completion 2021-09-30 1 site Stand-aloneOther conditions: Prostatic NeoplasmsView official trial listing → -
Status unknown NCT NCT01761656
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
Not yet reported Central South University 180 participants Est. completion 2014-02 1 site Stand-aloneCardiovascular disease Other conditions: Stable Angina, Unstable AnginaView official trial listing → -
Completed NCT NCT01763866
LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Not yet reported Amgen 2067 participants Est. completion 2013-12-04 244 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT01765023
Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects
Not yet reported HK inno.N Corporation 80 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01766076
Atorvastatin for HAART Suboptimal Responders
Not yet reported Makerere University 30 participants Est. completion 2014-03 Stand-aloneOther conditions: Acquired Immune Deficiency Syndrome VirusView official trial listing → -
Completed NCT NCT01768481
Intima Media Thickness Regression in Dyslipidemic Teenagers
Not yet reported Université de Montréal 16 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Obesity, DyslipidemiaView official trial listing → -
Completed NCT NCT01770210
Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events
Elpen Pharmaceutical Co. Inc. 670 participants Est. completion 2014-07 17 sitesOther conditions: Cardiovascular DisordersView official trial listing → -
Completed NCT NCT01779453
A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
Not yet reported Esperion Therapeutics, Inc. 58 participants Est. completion 2013-08 3 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01779687
Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Not yet reported Radboud University Medical Center 24 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HIV, HypercholesterolaemiaView official trial listing → -
Completed NCT NCT01780740
Statin Therapy In Atrial Refractoriness and Reperfusion Injury
Not yet reported University of Oxford 80 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Disorder; Heart, Functional, Postoperative, Cardiac Surgery, Cardiac Insufficiency Following Cardiac Surgery, Atrial Fibrillation, Ischaemia-reperfusion InjuryView official trial listing → -
Completed NCT NCT01780948
Pharmacokinetic of Everolimus and Atorvastatin Co-administration
Not yet reported Chulalongkorn University 18 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Difference of 12-hour AUCView official trial listing → -
Completed NCT NCT01785615
Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
Not yet reported, Not yet reported University of Rochester 116 participants Est. completion 2013-05 1 site Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT01795937
Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin
Not yet reported Boehringer Ingelheim 51 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01806324
A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects
Not yet reported HanAll BioPharma Co., Ltd. 30 participants Est. completion 2012-12 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01812707
Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan
Not yet reported Sanofi 100 participants Est. completion 2014-01 4 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01820767
Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients
Not yet reported Ricardo Mouzo Mirco 31 participants Est. completion 2014-03 2 sitesChronic kidney diseaseView official trial listing → -
Completed NCT NCT01821404
Atorvastatin Before Prostatectomy and Prostate Cancer
Not yet reported Tampere University Hospital 160 participants Est. completion 2017-05 3 sites Stand-aloneOther conditions: Prostatic NeoplasmsView official trial listing → -
Terminated NCT NCT01837069
Risk Factor Control Before Orthopedic Surgery
Not yet reported NYU Langone Health 198 participants Est. completion 2018-04-02 1 siteOsteoarthritisCardiovascular diseaseView official trial listing → -
Completed NCT NCT01842230
Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Essential Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01842256
Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Essential Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01856374
Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study
Not yet reported Yonsei University 60 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Multi-vessel Diseases, AnginaView official trial listing → -
Completed NCT NCT01857921
Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery
Not yet reported Yonsei University 290 participants Est. completion 2018-04-08 1 site Stand-aloneOther conditions: Coronary ArteryView official trial listing → -
Completed NCT NCT01859455
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
Not yet reported Novartis Pharmaceuticals 25 participants Est. completion 2012-07 2 sites Stand-aloneOther conditions: Hypercholesterolemia, LDL CholesterolView official trial listing → -
Terminated NCT NCT01863225
Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Not yet reported Resverlogix Corp 13 participants Est. completion 2013-06 1 site Stand-aloneCardiovascular disease Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01870804
Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)
Not yet reported Centro Cardiopatici Toscani 760 participants Est. completion 2016-09 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01890967
A Study of LY3015014 in Participants With High Cholesterol
Not yet reported Eli Lilly and Company 527 participants Est. completion 2014-06 49 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01922687
Amlodipine Plus/Minus Atorvastatin for Protection of Arteries
Not yet reported Shanghai Institute of Hypertension 109 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Arterial and Arteriolar DisordersView official trial listing → -
Status unknown NCT NCT01925079
Intensive Education on Lipid Management
Not yet reported Junbo Ge 2568 participants Est. completion 2015-06 5 sites Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT01925937
Atorvastatin/CoenzymeQ10 in Congestive Heart Failure
Not yet reported Isfahan University of Medical Sciences 30 participants 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01926782
Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)
Not yet reported Regeneron Pharmaceuticals 803 participants Est. completion 2015-04 83 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01929135
Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status.
Not yet reported Universidad de los Andes, Chile 38 participants Est. completion 2014-06 2 sites Stand-aloneOther conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT01936103
Effects of Intensive Statin Treatment on Left Ventricular Function
Not yet reported Shenyang Northern Hospital 120 participants Est. completion 2014-07 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01946815
Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
Not yet reported Keimyung University Dongsan Medical Center 119 participants Est. completion 2018-11 4 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01953328
Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk
Not yet reported Amgen 409 participants Est. completion 2014-06 54 sites Stand-aloneOther conditions: Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular EventsView official trial listing → -
Completed NCT NCT01954394
Open Label Study of Long Term Safety Evaluation of Alirocumab
Not yet reported Sanofi 986 participants Est. completion 2017-06-30 177 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01956201
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Not yet reported Chong Kun Dang Pharmaceutical 476 participants Est. completion 2016-08 30 sites Stand-aloneOther conditions: Mixed HyperlipidemiaView official trial listing → -
Completed NCT NCT01964326
Actual Use Trial of Atorvastatin Calcium 10 mg
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1311 participants Est. completion 2014-12 37 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01970215
TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)
Not yet reported Xention Ltd 364 participants Est. completion 2014-07 17 sitesOther conditions: DyslipidemiaView official trial listing → -
Terminated NCT NCT01972178
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Not yet reported Pronova BioPharma 113 participants Est. completion 2014-08 29 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Status unknown NCT NCT01974297
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Not yet reported Sang Hak Lee 194 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: Mixed HyperlipidemiaView official trial listing → -
Status unknown NCT NCT01974544
Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines
Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01980823
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Not yet reported Columbia University 23 participants Est. completion 2022-12 1 site Stand-aloneOther conditions: Breast Cancer, Breast Tumors, Cancer of BreastView official trial listing → -
Completed NCT NCT01984424
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3
Not yet reported Amgen 511 participants Est. completion 2017-11-21 58 sitesOther conditions: HyperlipidemiaView official trial listing → -
Withdrawn NCT NCT01987310
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
Not yet reported Sheba Medical Center Est. completion 2015-12 1 siteOther conditions: Non Alcoholic Fatty Liver DiseaseView official trial listing → -
Completed NCT NCT01988571
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Not yet reported Wake Forest University Health Sciences 279 participants Est. completion 2020-09-24 51 sitesOther conditions: Breast Cancer, LymphomaView official trial listing → -
Status unknown NCT NCT01997294
Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction
Not yet reported Zhang Qi, MD 1200 participants Est. completion 2017-02 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02001883
Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-12 1 siteCardiovascular diseaseView official trial listing → -
Suspended NCT NCT02022293
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 324 participants Est. completion 2024-01 6 sitesOther conditions: Nasopharyngeal Carcinoma, Radiation Therapy ComplicationView official trial listing → -
Status unknown NCT NCT02023892
Single Dose of Atorvastatin and Circulating Endothelial Microparticles
Not yet reported Sun Yat-sen University 30 participants Stand-aloneOther conditions: Endothelium, Hydroxymethylglutaryl-CoA Reductase InhibitorsView official trial listing → -
Completed NCT NCT02024373
Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma
Not yet reported Oriental Neurosurgery Evidence-Based-Study Team 200 participants Est. completion 2016-09 31 sites Stand-aloneOther conditions: Chronic Subdural HematomaView official trial listing → -
Completed NCT NCT02029118
Acupoint Application in Patients With Stable Angina Pectoris (AASAP)
Not yet reported Chengdu University of Traditional Chinese Medicine 200 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: Stable Angina PectorisView official trial listing → -
Status unknown NCT NCT02029534
Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)
Not yet reported Creighton University 200 participants Est. completion 2017-06 1 site Stand-aloneOther conditions: Cardiothoracic Surgery, Post-operative Atrial FibrillationView official trial listing → -
Completed NCT NCT02029573
Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
Not yet reported King Fahad Medical City 36 participants Est. completion 2016-12-31 1 site Stand-aloneOther conditions: Glioblastoma MultiformeView official trial listing → -
Status unknown NCT NCT02030054
Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)
Not yet reported University of Roma La Sapienza 150 participants Est. completion 2015-09 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02035215
Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 80 participants Est. completion 2014-12 4 sites Stand-aloneOther conditions: Hyperlipidemia, Familial CombinedView official trial listing → -
Completed NCT NCT02055976
Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects
Not yet reported Pfizer 218 participants Est. completion 2015-01 9 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02056340
Statin Therapy in Acute Influenza
Not yet reported Beth Israel Deaconess Medical Center 116 participants Est. completion 2018-06-30 1 siteOther conditions: InfluenzaView official trial listing → -
Completed NCT NCT02060032
1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 96 participants Est. completion 2013-11Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02066207
CKD-337 Drug Interaction Study
Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2014-05-29 1 site Stand-aloneOther conditions: Dyslipidemia (Fredrickson Type Ⅱa), Dyslipidemia (Fredrickson Type Ⅱb)View official trial listing → -
Completed NCT NCT02069821
Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects
Not yet reported HK inno.N Corporation 56 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02072161
Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
Not yet reported Esperion Therapeutics, Inc. 133 participants Est. completion 2015-01 40 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02080455
Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.
Not yet reported Aegerion Pharmaceuticals, Inc. 32 participants Est. completion 2014-03-07 1 site Stand-aloneOther conditions: Effect of Atorvastatin on the Pharmacokinetics of LomitapideView official trial listing → -
Completed NCT NCT02081638
Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 53 participants Est. completion 2019-10-16 2 sitesOther conditions: Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT02084069
Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair
Not yet reported Urmia University of Medical Sciences 58 participants Est. completion 2014-04 1 siteOther conditions: Heart Valve DiseasesView official trial listing → -
Completed NCT NCT02089061
Drug Interaction Statin
Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2014-05 Stand-aloneOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT02093390
A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects
Not yet reported Millennium Pharmaceuticals, Inc. 40 participants Est. completion 2014-04 Stand-aloneOther conditions: Prostate Cancer, EndometriosisView official trial listing → -
Completed NCT NCT02094313
Effects of Atorvastatin on Human Semen and Gonadal Hormones
Not yet reported University Hospital, Clermont-Ferrand 17 participants Est. completion 2014-01 1 site Stand-aloneOther conditions: Healthy Volunteers, Normocholesterolaemic Men, Normozoospermic MenView official trial listing → -
Completed NCT NCT02097589
The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23
Not yet reported University of Florida 33 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Healthy ControlsView official trial listing → -
Completed NCT NCT02098460
To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
Not yet reported Otsuka Beijing Research Institute 300 participants Est. completion 2016-03 1 siteOther conditions: Severe HypercholesterolemiaView official trial listing → -
Active, not recruiting NCT NCT02099123
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
Not yet reported Monash University 9971 participants Est. completion 2025-12 6 sites Stand-aloneOther conditions: Independent Living, Disability Free Survival, Elderly, HealthyView official trial listing → -
Completed NCT NCT02107898
Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)
Not yet reported Sanofi 216 participants Est. completion 2015-09 32 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02113540
Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
Not yet reported Isfahan University of Medical Sciences 1 site Stand-aloneOther conditions: Contrast Induced NephropathyView official trial listing → -
Status unknown NCT NCT02114099
Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease
Not yet reported National Taiwan University Hospital 20 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Kawasaki Disease, Aneurysm, CoronaryView official trial listing → -
Completed NCT NCT02114346
High Dose Atorvastatin for Preventing Contrast-induced Nephropathy
Not yet reported, Not yet reported Isfahan University of Medical Sciences 250 participants Est. completion 2014-02 1 site Stand-aloneOther conditions: Contrast-Induced NephropathyView official trial listing → -
Completed NCT NCT02119520
PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS
Not yet reported Government Dental College and Research Institute, Bangalore 96 participants Est. completion 2014-02 1 siteOther conditions: PeriodontitisView official trial listing → -
Completed NCT NCT02125682
The HDL Particle Protection Study
Not yet reported Hotel Dieu de France Hospital 16 participants Est. completion 2017-05-14 1 siteOther conditions: Dyslipidemia in Patients With Diabetes MellitusView official trial listing → -
Terminated NCT NCT02133534
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
Not yet reported Duke University 1 participants Est. completion 2009-05 Stand-aloneChronic kidney disease Other conditions: High CholesterolView official trial listing → -
Completed NCT NCT02133807
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
Not yet reported Russian Cardiology Research and Production Center 32 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: Atherosclerosis, Coronary Disease, Carotid Artery DiseasesView official trial listing → -
Completed NCT NCT02135029
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
Not yet reported Pfizer 184 participants Est. completion 2015-11 40 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02155530
COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial
Not yet reported Yonsei University 30 participants Est. completion 2016-06 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02156492
A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants
Not yet reported Eli Lilly and Company 62 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02157337
The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery
Not yet reported Yonsei University 23 participants Est. completion 2015-05-29 1 site Stand-aloneOther conditions: Aortic Surgery, Acute Kidney InjuryView official trial listing → -
Completed NCT NCT02160743
The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects
Not yet reported HK inno.N Corporation 28 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Food Effect Study of CJ-30056 20mg/500mgView official trial listing → -
Completed NCT NCT02166593
Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin
Not yet reported Yooyoung Pharmaceutical Co., Ltd. 302 participants Est. completion 2018-01 1 site Stand-aloneOther conditions: Combined DyslipidemiaView official trial listing → -
Completed NCT NCT02171039
Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers
Not yet reported Boehringer Ingelheim 24 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02185066
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR
Not yet reported HK inno.N Corporation 42 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02189837
Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
Not yet reported Amgen 89 participants Est. completion 2015-03-05 2 sites Stand-aloneOther conditions: Primary Hyperlipidemia and Mixed DyslipidemiaView official trial listing → -
Status unknown NCT NCT02192320
The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders
Not yet reported Oriental Neurosurgery Evidence-Based-Study Team 60 participants Est. completion 2015-09 2 sites Stand-aloneOther conditions: Chronic Subdural HematomaView official trial listing → -
Completed NCT NCT02197065
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Not yet reported Hospital for Special Surgery, New York 20 participants Est. completion 2017-01 2 sites Stand-aloneOther conditions: Hip Fracture, Myocardial Ischemia, InflammationView official trial listing → -
Withdrawn NCT NCT02201381
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer
Not yet reported Health Clinics Limited Est. completion 2027-09-23 1 site Stand-aloneOther conditions: Cancer, Overall SurvivalView official trial listing → -
Terminated NCT NCT02205775
Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty
Not yet reported G. d'Annunzio University 280 participants Est. completion 2012-06 6 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02207634
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Not yet reported Amgen 1974 participants Est. completion 2016-11-11 416 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Status unknown NCT NCT02219191
Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases
Not yet reported Chengdu PLA General Hospital 150 participants Est. completion 2018-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02225834
Atorvastatin in Acute Stroke Treatment
Not yet reported University of Palermo 50 participants Est. completion 2014-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02227784
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Not yet reported Eli Lilly and Company 366 participants Est. completion 2015-12 64 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02243098
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
Not yet reported Novo Nordisk A/S 31 participants Est. completion 2015-04-07 1 site Added to GLP-1Other conditions: Diabetes, HealthyView official trial listing → -
Terminated NCT NCT02245087
Eliminate Coronary Artery Disease
Not yet reported University Health Network, Toronto 28 participants Est. completion 2019-09 3 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02245269
Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers
Not yet reported Boehringer Ingelheim 23 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02254824
Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 300 participants Est. completion 2016-10 1 siteOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT02260648
A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia
Not yet reported Eli Lilly and Company 149 participants Est. completion 2015-11 8 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02278471
The SCCS Polypill Pilot Trial
Not yet reported Vanderbilt University 303 participants Est. completion 2018-06-27 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02286544
Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
Not yet reported Karolinska Institutet 36 participants Est. completion 2015-12 1 site Stand-aloneCardiovascular disease Other conditions: Inflammation, Acute Coronary Syndrome (ACS), Reperfusion InjuryView official trial listing → -
Completed NCT NCT02288338
CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
Not yet reported Chong Kun Dang Pharmaceutical 36 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02289963
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Not yet reported Sanofi 199 participants Est. completion 2016-04 27 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02292069
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition
Not yet reported Dr. Reddy's Laboratories Limited 90 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02295046
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
Not yet reported Dr. Reddy's Laboratories Limited 80 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02305355
Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 site Stand-aloneType 2 diabetes Other conditions: HypertriglycemiaView official trial listing → -
Completed NCT NCT02314208
Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 12 participants Est. completion 2018-01-01 1 siteOther conditions: Spastic Paraplegia, HereditaryView official trial listing → -
Status unknown NCT NCT02323425
Effects of Limb Ischemic Postconditioning in Young sICAS
Not yet reported Xi'an Jiaotong University 100 participants Est. completion 2018-03 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02331095
Statin Use in Patients With Acute VTE
Not yet reported Ohio State University 21 participants Est. completion 2020-05-20 1 site Stand-aloneOther conditions: Venous ThromboembolismView official trial listing → -
Completed NCT NCT02342015
Effect of Atorvastatin on Bone-vascular Axis
Not yet reported University of Padova 20 participants Est. completion 2014-03 Stand-aloneOther conditions: Osteoporosis, HypercholesterolemiaView official trial listing → -
Completed NCT NCT02347098
Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II
Not yet reported VA Office of Research and Development 270 participants Est. completion 2019-09-30 4 sites Stand-aloneOther conditions: Acute Coronary Artery SyndromeView official trial listing → -
Status unknown NCT NCT02350959
Adverse Plaque Characteristics in CCTA and TVC Imaging
Not yet reported National Health Insurance Service Ilsan Hospital 100 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: PlaqueView official trial listing → -
Completed NCT NCT02355704
Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney
Not yet reported Instituto Mexicano del Seguro Social 48 participants Est. completion 2014-07 1 siteOther conditions: Renal InsufficiencyView official trial listing → -
Completed NCT NCT02357212
Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome
Not yet reported University of Florida 40 participants Est. completion 2013-09Other conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT02363725
Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response
Not yet reported University Hospital, Montpellier 44 participants Est. completion 2016-08 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02364258
Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients
Not yet reported Children's Mercy Hospital Kansas City 28 participants Est. completion 2017-12-27 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02370784
Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Not yet reported Robyn T. Domsic, MD, MPH 24 participants Est. completion 2019-12-15 1 siteOther conditions: SclerodermaView official trial listing → -
Completed NCT NCT02374047
A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects
Not yet reported Catabasis Pharmaceuticals 118 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02378441
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
Not yet reported HK inno.N Corporation 42 participants Est. completion 2015-08 Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02380625
Multiple Treatments for Ebola Virus Disease (EVD)
Not yet reported, Not yet reported Clinical Research Management, Inc. 150 participants Est. completion 2016-03 Stand-aloneOther conditions: Ebola Virus DiseaseView official trial listing → -
Completed NCT NCT02386033
Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 60 participants Est. completion 2014-07Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02392416
Atorvastatin Study in Cardiovascular Disease Risk
Elpen Pharmaceutical Co. Inc. 900 participants Est. completion 2016-02 2 sitesOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT02397590
Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers
Not yet reported Boryung Pharmaceutical Co., Ltd 36 participants Est. completion 2015-06 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02411903
The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
Not yet reported The Third Affiliated Hospital of Guangzhou Medical University 160 participants Est. completion 2016-08Other conditions: Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder)View official trial listing → -
Status unknown NCT NCT02416427
Targeting the Hippo Transducer TAZ in Breast Cancer With Statins
Not yet reported Regina Elena Cancer Institute 78 participants Est. completion 2016-12 Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02422030
CKD-337(2) Drug-drug Interaction Study
Not yet reported Chong Kun Dang Pharmaceutical 30 participants Est. completion 2015-04-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02432040
Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis
Not yet reported Philippine Dermatological Society 28 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT02432534
Atorvastatin in Active Vitiligo
Not yet reported Centre Hospitalier Universitaire de Nice 28 participants Est. completion 2017-12 2 sites Stand-aloneOther conditions: VitiligoView official trial listing → -
Completed NCT NCT02437084
Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Not yet reported Stanford University 115 participants Est. completion 2020-04 1 siteType 2 diabetes Other conditions: Hyperlipidemia, Insulin ResistanceView official trial listing → -
Completed NCT NCT02451098
Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
Not yet reported Chong Kun Dang Pharmaceutical 385 participants Est. completion 2016-01 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02452502
The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 254 participants Est. completion 2018-08 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02455869
Comparison of Alendronate With Atorvastatin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 104 participants Est. completion 2015-03Other conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT02458755
Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis
Not yet reported Samsung Medical Center 80 participants Est. completion 2018-06 1 site Stand-aloneCardiovascular disease Other conditions: Intracranial AtherosclerosisView official trial listing → -
Completed NCT NCT02460159
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
Not yet reported Organon and Co 135 participants Est. completion 2016-12-22Other conditions: Hypercholesterolemia, Heterozygous Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT02461004
CKD-391 Pharmacokinetic Study
Not yet reported Chong Kun Dang Pharmaceutical 52 participants Est. completion 2015-10 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02470455
Effect of Atorvastatin on Glycemic Control in Prediabetic Patients
Shri Ramachandra Bhanj Medical College 75 participants Est. completion 2012-12 1 siteOther conditions: Prediabetic StateView official trial listing → -
Completed NCT NCT02476006
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Not yet reported Sanofi 998 participants Est. completion 2019-04-12 153 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02496962
Protective Effect of Statin on Sleep Deprivation
Not yet reported Shi Yang 72 participants 1 site Stand-aloneOther conditions: Sleep DeprivationView official trial listing → -
Withdrawn NCT NCT02497638
LIpitor and biGuanide to Androgen Delay Trial
Not yet reported University Health Network, Toronto Est. completion 2022-12 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02501200
CKD-391 Pharmacokinetic Study Phase I
Not yet reported Chong Kun Dang Pharmaceutical 46 participants Est. completion 2015-12Other conditions: HealthyView official trial listing → -
Completed NCT NCT02503865
Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
Not yet reported, Not yet reported Nazarbayev University 351 participants Est. completion 2014-12 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT02516111
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 120 participants Est. completion 2015-05Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02518503
High Potency Statins and the Risk of Diabetes
Canadian Network for Observational Drug Effect Studies, CNODES 136966 participants Est. completion 2013-02Type 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02518516
High Potency Statins and Acute Kidney Injury
Canadian Network for Observational Drug Effect Studies, CNODES 2067639 participants Est. completion 2013-01 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02522117
Atorvastatin in the Recipient's Kidney Graft From a Living Donor
Not yet reported Instituto Mexicano del Seguro Social 48 participants Est. completion 2018-01 1 siteOther conditions: Renal InsufficiencyView official trial listing → -
Terminated NCT NCT02539810
Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)
Not yet reported Assistance Publique - Hôpitaux de Paris 4 participants Est. completion 2017-07 15 sites Stand-aloneOther conditions: Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 PercentView official trial listing → -
Completed NCT NCT02549846
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
Not yet reported Hyogo Medical University 270 participants Est. completion 2017-03 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02550288
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
Not yet reported Organon and Co 309 participants Est. completion 2016-05-30 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02565615
Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 5115 participants Est. completion 2018-08-31 54 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02566187
A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet
Not yet reported Boryung Pharmaceutical Co., Ltd 99 participants Est. completion 2015-10 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02577042
Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen
Not yet reported Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 42 participants Est. completion 2018-06-04 1 site Stand-aloneOther conditions: Aging-related Inflammation in HIV-infected PatientsView official trial listing → -
Completed NCT NCT02579356
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
Not yet reported Samil Pharmaceutical Co., Ltd. 48 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Diseases of the Circulatory System, Essential HypertensionView official trial listing → -
Status unknown NCT NCT02579499
Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
Not yet reported Yonsei University 4400 participants Est. completion 2022-11 1 site Stand-aloneOther conditions: Coronary Artery DiseasseView official trial listing → -
Completed NCT NCT02584504
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
Not yet reported Sanofi 163 participants Est. completion 2018-01-09 30 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Not yet reported Resverlogix Corp 2425 participants Est. completion 2021-06-21 214 sites Stand-aloneType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02587416
Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
Not yet reported NeuroBo Pharmaceuticals Inc. 20 participants Est. completion 2002-12 Stand-aloneOther conditions: HypercholesteremiaView official trial listing → -
Status unknown NCT NCT02588235
Ezetimibe and Atorvastatin Therapy on TCFA
Not yet reported Xijing Hospital 100 participants Est. completion 2017-11 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02590653
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
Not yet reported Penza State University 200 participants Est. completion 2020-02 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02591836
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin
Not yet reported NeuroBo Pharmaceuticals Inc. 277 participants Est. completion 2003-06 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02596126
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2499 participants Est. completion 2022-03-31 113 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02600520
Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 45 participants Est. completion 2015-05Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02603328
Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
Not yet reported, Not yet reported University of Chicago 80 participants Est. completion 2025-03-31 1 siteOther conditions: Cerebral Cavernous MalformationView official trial listing → -
Completed NCT NCT02608697
A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
Not yet reported Catabasis Pharmaceuticals 153 participants Est. completion 2016-06 34 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02609711
Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects
Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 90 participants 1 siteOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT02612792
Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 82 participants Est. completion 2015-08 1 siteOther conditions: Furcation DefectsView official trial listing → -
Status unknown NCT NCT02614352
Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects
Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 60 participants Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT02633956
Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
Not yet reported Intercept Pharmaceuticals 84 participants Est. completion 2018-03-12 22 sites Stand-aloneMASHView official trial listing → -
Completed NCT NCT02641899
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
Not yet reported Intarcia Therapeutics 33 participants Est. completion 2016-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02651753
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2016-05Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02659397
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Not yet reported Esperion Therapeutics, Inc. 68 participants Est. completion 2016-07 19 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02662569
Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia
Not yet reported Amgen 986 participants Est. completion 2017-12-06 110 sites Stand-aloneOther conditions: Diabetes, Hyperlipidemia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT02668016
Self-Assessment Method for Statin Side-effects Or Nocebo
Not yet reported Imperial College London 60 participants Est. completion 2020-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Adverse Effects, HyperlipidemiasView official trial listing → -
Terminated NCT NCT02674204
STOP Heart Disease in Breast Cancer Survivors Trial
Not yet reported Cedars-Sinai Medical Center 2 participants Est. completion 2018-05-25 1 site Stand-aloneOther conditions: Breast Cancer, Heart Disease, Cardiotoxicity, Myocardial DysfunctionView official trial listing → -
Completed NCT NCT02679261
Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve
Not yet reported Hospital Universitari Vall d'Hebron Research Institute 220 participants Est. completion 2021-02 10 sites Stand-aloneOther conditions: Bicuspid Aortic ValveView official trial listing → -
Completed NCT NCT02681653
Study the Impact of Statins in Septic Shock
Not yet reported Sanjay Gandhi Postgraduate Institute of Medical Sciences 40 participants Est. completion 2015-01 2 sitesOther conditions: Septic ShockView official trial listing → -
Completed NCT NCT02685462
Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
Not yet reported Tobira Therapeutics, Inc. 36 participants Est. completion 2016-02-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02706860
Efficacy of Different Perioperative Statin Regimens on the Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events
Not yet reported Cairo University 94 participants Est. completion 2015-02 Stand-aloneOther conditions: Coronary Artery Bypass GraftingView official trial listing → -
Completed NCT NCT02714569
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
Not yet reported Eli Lilly and Company 60 participants Est. completion 2017-02-15 4 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT02715726
Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
Not yet reported Sanofi 615 participants Est. completion 2018-08-06 62 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02726555
The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin
Not yet reported Wenzhou Medical University 240 participants Est. completion 2026-05 1 site Stand-aloneOther conditions: Dyslipidemia, AtherosclerosisView official trial listing → -
Terminated NCT NCT02740699
CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 79 participants Est. completion 2022-03-11 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02749578
Drug Interaction Study of MGL-3196 With Atorvastatin
Not yet reported Madrigal Pharmaceuticals, Inc. 14 participants Est. completion 2016-05 1 siteOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT02764736
Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)
Not yet reported Albert Einstein Healthcare Network Est. completion 2017-03-22 Stand-aloneOther conditions: Complication of Renal DialysisView official trial listing → -
Completed NCT NCT02767362
A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
Not yet reported UNC Lineberger Comprehensive Cancer Center 24 participants Est. completion 2019-09-26 1 site Stand-aloneOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT02767401
The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)
Not yet reported The First Affiliated Hospital of Dalian Medical University 200 participants Est. completion 2018-12-15Other conditions: Hibernation, Myocardial, Complete Occlusion of Coronary ArteryView official trial listing → -
Completed NCT NCT02776956
Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy
Not yet reported xieruiqin 180 participants Est. completion 2018-08 1 site Stand-aloneOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT02781064
STATIN: Web-based Investigation of Side Effects
Not yet reported London School of Hygiene and Tropical Medicine 200 participants Est. completion 2019-08-08 58 sitesCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT02790528
Statin Therapy In Patients With Vasospastic Angina
Not yet reported Seung-Jung Park Est. completion 2023-12 1 site Stand-aloneOther conditions: Angina Pectoris, Variant, Statins, HMG-CoAView official trial listing → -
Status unknown NCT NCT02791958
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Not yet reported Ferrer Internacional S.A. 528 participants Est. completion 2017-10 36 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02800174
Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis
Not yet reported Beijing Jishuitan Hospital 103 participants Est. completion 2008-06 Stand-aloneOther conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT02800902
Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 90 participants Est. completion 2016-02 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Terminated NCT NCT02819869
The Combination Effect of Statin Plus Metformin on Relapse-free
Not yet reported Taipei Medical University WanFang Hospital 3 participants Est. completion 2016-12-14 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT02842359
Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Not yet reported Sanofi 11 participants Est. completion 2018-04-19 1 site Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT02850081
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT02863185
Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
Not yet reported Dong-A University 45 participants Est. completion 2020-12-31 2 sitesChronic kidney diseaseView official trial listing → -
Completed NCT NCT02901379
Effect of 80-mg Atorvastatin on Myocardial Edema
Not yet reported National Cardiovascular Center Harapan Kita Hospital Indonesia 40 participants Est. completion 2018-08 Stand-aloneOther conditions: Myocardial EdemaView official trial listing → -
Completed NCT NCT02910778
The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
Not yet reported Medical University of Vienna 32 participants Est. completion 2017-03 1 site Stand-aloneOther conditions: IschemiaView official trial listing → -
Completed NCT NCT02913664
Risk Reduction for Alzheimer's Disease
Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-aloneOther conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02938949
Alirocumab in Patients With Acute Myocardial Infarction
Not yet reported Virginia Commonwealth University 20 participants Est. completion 2018-08-16 1 siteCardiovascular disease Other conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02940366
Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome
Not yet reported Seoul National University Hospital 500 participants Est. completion 2019-11-30 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT02942602
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
Not yet reported Yonsei University 58 participants Est. completion 2016-05-23 1 site Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02943590
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Not yet reported Massachusetts General Hospital 300 participants Est. completion 2023-10-11 4 sites Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT02947620
Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
Not yet reported Daewoong Pharmaceutical Co. LTD. 185 participants Est. completion 2017-02-27 1 siteOther conditions: Type II Diabetes, DyslipidemiaView official trial listing → -
Completed NCT NCT02957162
The Effect on EPCs by Statin Loading in "All Comers" With an ACS
Not yet reported University Hospitals of North Midlands NHS Trust 40 participants Est. completion 2017-09-25 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT02958852
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02967653
Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus
Not yet reported Lady Davis Institute 60 participants Est. completion 2019-07-01 3 sites Stand-aloneOther conditions: Lithium Use, Nephrogenic Diabetes InsipidusView official trial listing → -
Completed NCT NCT02977065
To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
Not yet reported Chong Kun Dang Pharmaceutical 62 participants Est. completion 2018-01-30 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT02979704
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Not yet reported, Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90 participants Est. completion 2017-07 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02984293
Statin Immune Study
Not yet reported University of Dundee 18 participants Est. completion 2017-11-03 1 siteOther conditions: Drug IntoleranceView official trial listing → -
Completed NCT NCT02984982
Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Not yet reported Sanofi 206 participants Est. completion 2018-07-27 39 sites Stand-aloneOther conditions: Hypercholesterolemia, Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT02994745
A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.
Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-08 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Terminated NCT NCT03004001
Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
Not yet reported Gloria Vega 3 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT03009097
Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
Not yet reported Kamineni Institute of Dental Sciences 26 participants Est. completion 2014-08Other conditions: Chronic Periaortitis, Intrabony Periodontal DefectView official trial listing → -
Completed NCT NCT03018444
The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion
Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2017-01 1 site Stand-aloneType 2 diabetes Other conditions: Hydroxymethylglutaryl-CoA Reductase InhibitorsView official trial listing → -
Active, not recruiting NCT NCT03024684
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment
Not yet reported Chiayi Christian Hospital 240 participants Est. completion 2027-01 6 sites Stand-aloneOther conditions: HepatoCellular CarcinomaView official trial listing → -
Completed NCT NCT03031119
Multiple Ascending Dose and DDI Study
Not yet reported Pfizer 62 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT03037372
Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial
Not yet reported Makerere University 320 participants Est. completion 2022-12-31 Stand-aloneOther conditions: HIV InfectionView official trial listing → -
Withdrawn NCT NCT03047538
Fixed Combination for Lipid and Blood Pressure Control
Not yet reported Charles University, Czech Republic Est. completion 2019-12-31 1 siteOther conditions: Arterial Hypertension, Dyslipidemias, Blood Pressure, Lipid Metabolism DisordersView official trial listing → -
Status unknown NCT NCT03047772
Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
Not yet reported Yuejin Yang 124 participants Est. completion 2018-12-31 Stand-aloneCardiovascular disease Other conditions: Stem Cell Transplantation, Angioplasty, Transluminal, Percutaneous CoronaryView official trial listing → -
Completed NCT NCT03051100
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
Not yet reported Esperion Therapeutics, Inc. 63 participants Est. completion 2017-07-05 11 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03054467
Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina
Not yet reported Kosin University Gospel Hospital 150 participants Est. completion 2019-04-28Other conditions: Quality of LifeView official trial listing → -
Status unknown NCT NCT03061487
Influence of Statins in Artery Aneurysms
University of Catanzaro 20 participants Est. completion 2018-04-27 1 siteOther conditions: Statin, Aneurysm, Extracellular Matrix AlterationView official trial listing → -
Withdrawn NCT NCT03066466
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Not yet reported Loyola University Est. completion 2021-02-28 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Status unknown NCT NCT03072082
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization
Not yet reported Jun Li 440 participants Est. completion 2019-02 Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03072121
Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization
Not yet reported Jun Li 440 participants Est. completion 2019-02 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03073863
Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study
Not yet reported Korea University Guro Hospital 10001 participants Est. completion 2007-05-01 Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03079115
High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
Not yet reported Beijing Hospital 130 participants Est. completion 2020-04-30 1 siteOther conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT03110848
Effects of Atorvastatin in Graves' Orbitopathy (GO)
Not yet reported University of Pisa 88 participants Est. completion 2021-04-30 1 site Stand-aloneOther conditions: Thyroid Associated Ophthalmopathy, HypercholesterolemiaView official trial listing → -
Completed NCT NCT03122639
Endothelial Function in Obstructive Sleep Apnea
Not yet reported Columbia University 106 participants Est. completion 2021-05-07 1 siteObstructive sleep apneaView official trial listing → -
Active, not recruiting NCT NCT03127631
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Not yet reported McMaster University 5000 participants Est. completion 2026-12-31 61 sitesCardiovascular disease Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03133260
A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery
Parc de Salut Mar 800 participants Est. completion 2021-10-15 1 siteOther conditions: Myocardium; InjuryView official trial listing → -
Suspended NCT NCT03176498
Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.
Not yet reported, Not yet reported Sclnow Biotechnology Co., Ltd. 40 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Cerebral InfarctionView official trial listing → -
Status unknown NCT NCT03186404
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
Not yet reported University Health Network, Toronto 112 participants Est. completion 2023-12 1 site Stand-aloneHeart failure Other conditions: Cancer, CardiotoxicityView official trial listing → -
Withdrawn NCT NCT03188978
High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study
Not yet reported, Not yet reported Albany Medical College Est. completion 2019-12-31 1 site Stand-aloneOther conditions: Primary Arteriovenous Fistula FailureView official trial listing → -
Status unknown NCT NCT03195153
Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin
Not yet reported University of Roma La Sapienza 200 participants Est. completion 2017-07-15 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03207698
PRF+1% MF for Class II Mandibular Furcation Defects
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 75 participants Est. completion 2016-05 1 siteOther conditions: Furcation DefectsView official trial listing → -
Completed NCT NCT03218293
Thrombolysis and RIPC in Acute Ischemic Stroke
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 68 participants Est. completion 2020-10-31 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT03228017
Subclinical Cardiovascular Disease in Psoriatic Disease
Not yet reported NYU Langone Health 63 participants Est. completion 2019-04-01 1 siteCardiovascular disease Other conditions: Thrombotic Vascular DiseaseView official trial listing → -
Terminated NCT NCT03228238
ANti-Oxidant in Variant Angina (ANOVA) Trial
Not yet reported Seoul National University Hospital 320 participants Est. completion 2024-06-01 1 site Stand-aloneOther conditions: Variant AnginaView official trial listing → -
Completed NCT NCT03228771
Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study)
Not yet reported Ain Shams University 30 participants Est. completion 2018-08-15 1 siteOther conditions: Socket PreservationView official trial listing → -
Completed NCT NCT03231137
Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination
Not yet reported Ain Shams University 50 participants Est. completion 2017-07-10 Stand-aloneOther conditions: Alveolar Socket PreservationsView official trial listing → -
Completed NCT NCT03247400
The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo
Not yet reported, Not yet reported Nicolaus Copernicus University 24 participants Est. completion 2019-04-30 1 siteOther conditions: Non-segmental VitiligoView official trial listing → -
Completed NCT NCT03255044
Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure
Not yet reported Ain Shams University 85 participants Est. completion 2019-04-01 1 siteHeart failureView official trial listing → -
Completed NCT NCT03273972
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
Not yet reported Cambridge University Hospitals NHS Foundation Trust 30 participants Est. completion 2018-10-10 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Terminated NCT NCT03275376
Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma
Not yet reported Taichung Veterans General Hospital 34 participants Est. completion 2021-03-13 1 site Stand-aloneOther conditions: Overall Survival, Tumor ResponsesView official trial listing → -
Status unknown NCT NCT03289429
Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery
Not yet reported Assiut University 96 participants Est. completion 2018-02 1 site Stand-aloneOther conditions: ArrhythmiasView official trial listing → -
Completed NCT NCT03308578
Statins and CPAP in Adipose Tissue of OSA
Not yet reported, Not yet reported Mayo Clinic 50 participants Est. completion 2023-12-12 1 site Stand-aloneOther conditions: Sleep Apnea, ObstructiveView official trial listing → -
Completed NCT NCT03311841
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
Not yet reported Merck Sharp & Dohme LLC 32 participants Est. completion 2018-08-02 2 sites Stand-aloneOther conditions: Renal InsufficiencyView official trial listing → -
Withdrawn NCT NCT03318484
Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University Est. completion 2019-11 Stand-aloneCardiovascular disease Other conditions: Peripheral Arterial Disease, AtherosclerosisView official trial listing → -
Completed NCT NCT03338426
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
Not yet reported Boryung Pharmaceutical Co., Ltd 133 participants Est. completion 2019-04-22 1 site Stand-aloneOther conditions: Essential Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT03346187
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
Not yet reported Chong Kun Dang Pharmaceutical 60 participants Est. completion 2017-06-13 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03351998
Impact of Statin Therapy on Muscle Mitochondrial Function and Aerobic Capacity
Not yet reported University of Kansas Medical Center 68 participants Est. completion 2023-07-07 2 sitesOther conditions: Mitochondrial DiseasesView official trial listing → -
Status unknown NCT NCT03355027
Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease
Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2023-11-30 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT03358017
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
Not yet reported Mario Negri Institute for Pharmacological Research 54 participants Est. completion 2023-07-25 9 sites Stand-aloneOther conditions: Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT03360916
Impact of Statin Therapy on Adaptations to Aerobic Exercise
Not yet reported University of Kansas Medical Center 52 participants Est. completion 2024-06-05 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03370705
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
Not yet reported Alfa Wassermann Tunisia 156 participants Est. completion 2020-03-30 3 sitesOther conditions: Peripheral Arterial Obstructive DiseaseView official trial listing → -
Status unknown NCT NCT03372785
The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease
Beijing Anzhen Hospital 240 participants Est. completion 2022-04 1 siteCardiovascular disease Other conditions: Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Viable MyocardiumView official trial listing → -
Completed NCT NCT03382756
A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337
Not yet reported Chong Kun Dang Pharmaceutical 16 participants Est. completion 2017-11-07 1 siteOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03391830
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
Not yet reported Mansoura University 250 participants Est. completion 2020-01-01 1 siteOther conditions: Contrast-induced Nephropathy, Statin, Ascorbic Acid, AKIView official trial listing → -
Completed NCT NCT03411291
Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study
Cedars-Sinai Medical Center 18 participants Est. completion 2010-09 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Status unknown NCT NCT03414840
Assessment of Change in Atherosclerotic Plaque by Serial CCTA
Yonsei University 400 participants Est. completion 2020-10-31 1 siteCardiovascular disease Other conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT03415178
Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Not yet reported Sanofi 69 participants Est. completion 2018-08-09 13 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Active, not recruiting NCT NCT03417388
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03418974
Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
Not yet reported Fudan University 10000 participants Est. completion 2021-12-31 2 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03431909
Evaluation Of HUK in Acute Stroke Patients: MRS and CTP
Not yet reported Xuanwu Hospital, Beijing 80 participants Est. completion 2016-10-01Cardiovascular diseaseView official trial listing → -
Completed NCT NCT03433196
Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
Not yet reported Zhejiang Hisun Pharmaceutical Co. Ltd. 255 participants Est. completion 2018-10-10 Stand-aloneOther conditions: Hypercholesterolemia in Coronaory Heart DiseaseView official trial listing → -
Status unknown NCT NCT03438955
Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
Not yet reported DongKoo Bio & Pharma 48 participants Est. completion 2018-08-31 1 siteOther conditions: Hyperlipidemia, HypertriglyceridemiaView official trial listing → -
Status unknown NCT NCT03460808
The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Not yet reported, Not yet reported Peking University People's Hospital 200 participants Est. completion 2023-01-01 1 site Stand-aloneOther conditions: Immune ThrombocytopeniaView official trial listing → -
Completed NCT NCT03461081
Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 32 participants Est. completion 2017-12-12 1 site Stand-aloneOther conditions: Hypertension With HyperlipidemiaView official trial listing → -
Status unknown NCT NCT03464682
Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia
Not yet reported Zhejiang Hisun Pharmaceutical Co. Ltd. 720 participants Est. completion 2019-05-28 Stand-aloneOther conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT03482180
Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 215 participants Est. completion 2018-03-23Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03504735
Caduet and TLC Intervention in Metabolic Syndrome
Not yet reported The University of Texas Medical Branch, Galveston 53 participants Est. completion 2016-02-28Metabolic syndromeView official trial listing → -
Terminated NCT NCT03507374
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
Not yet reported University of Utah 20 participants Est. completion 2020-04-17 1 siteCardiovascular disease Other conditions: Intracranial Atherosclerosis, Intraplaque HemorrhageView official trial listing → -
Completed NCT NCT03510715
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Not yet reported Sanofi 18 participants Est. completion 2020-02-17 10 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03510884
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Not yet reported Sanofi 153 participants Est. completion 2022-08-05 43 sites Stand-aloneOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT03515772
Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients
Centre Hospitalier Universitaire Vaudois 21 participants Est. completion 2019-08-29 2 sitesCardiovascular disease Other conditions: HIV Infections, Drug InteractionsView official trial listing → -
Status unknown NCT NCT03532620
China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
Not yet reported Jun Tao 396 participants Est. completion 2020-09 13 sitesOther conditions: Prediabetic State, Hypertension, DyslipidemiasView official trial listing → -
Status unknown NCT NCT03541109
A Polypill for Secondary Prevention of Ischemic Heart Disease
Not yet reported Isfahan University of Medical Sciences 1200 participants Est. completion 2024-08 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT03560882
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
Not yet reported Joaquina Baranda 50 participants Est. completion 2026-08-01 1 site Stand-aloneOther conditions: Malignant Disease, Solid Tumor, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Cancer, Relapsed Hematologic MalignancyView official trial listing → -
Completed NCT NCT03570697
Imaging of Coronary Plaques in Participants Treated With Evolocumab
Not yet reported Amgen 164 participants Est. completion 2021-01-21 33 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03604471
Lipid-lowering Therapy Individualization
Not yet reported Université Catholique de Louvain 75 participants Est. completion 2019-08-27 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03610217
Pragmatic Clinical Trials in Scleroderma
Not yet reported University of West London 400 participants Est. completion 2021-10 1 site Stand-aloneOther conditions: Scleroderma, Systemic, Sclerosis, SystemicView official trial listing → -
Status unknown NCT NCT03610321
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 70 participants Est. completion 2021-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03611010
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
Not yet reported Cumberland Pharmaceuticals 40 participants Est. completion 2020-02-24 1 site Stand-aloneOther conditions: Hypercholesterolemia, DyslipidemiasView official trial listing → -
Withdrawn NCT NCT03625089
Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis
Not yet reported Chinese University of Hong Kong Est. completion 2020-09-30 1 site Stand-aloneOther conditions: Arthritis, Rheumatoid, Arthritis, PsoriaticView official trial listing → -
Status unknown NCT NCT03635749
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
Not yet reported Beijing Tiantan Hospital 6100 participants Est. completion 2023-10-30 113 sitesCardiovascular disease Other conditions: Transient Ischemic AttackView official trial listing → -
Status unknown NCT NCT03639480
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
Not yet reported HK inno.N Corporation 180 participants Est. completion 2018-10 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03657472
Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
Not yet reported HK inno.N Corporation 42 participants Est. completion 2016-11-09 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03660293
Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs
Not yet reported Tanta University 150 participants Est. completion 2019-06-01 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT03692754
Atorvastatin in Management of Newly Diagnosed ITP
Not yet reported, Not yet reported Shandong University 30 participants Est. completion 2023-12-01 1 siteOther conditions: Immune Thrombocytopenia, Purpura, ThrombocytopenicView official trial listing → -
Status unknown NCT NCT03696940
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
Not yet reported Laboratorios Grossman, S.A. 120 participants Est. completion 2019-08-31 1 site Stand-aloneOther conditions: Dyslipidemias, Cardiovascular Risk FactorView official trial listing → -
Status unknown NCT NCT03703635
Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis
Not yet reported Ministry of Science and Technology of the People´s Republic of China 512 participants Est. completion 2025-05 31 sites Stand-aloneOther conditions: Intracranial Artery StenosisView official trial listing → -
Completed NCT NCT03709355
Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs
Not yet reported Viriom 56 participants Est. completion 2019-09-06 1 site Stand-aloneOther conditions: HIV-1-infectionView official trial listing → -
Completed NCT NCT03745300
Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 120 participants Est. completion 2017-12-22 1 siteOther conditions: Chronic Periodontitis Wth Diabetes MellitusView official trial listing → -
Withdrawn NCT NCT03750760
Early Alirocumab to Reduce LDL-C in Myocardial Infarction
Not yet reported Imperial College London Est. completion 2021-12 17 sitesCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03760848
Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers
Not yet reported Galmed Pharmaceuticals Ltd 15 participants Est. completion 2019-02-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03768427
Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)
Not yet reported Organon and Co 454 participants Est. completion 2021-04-01 30 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03769870
Teneligliptin and Atorvastatin DDI Study
Not yet reported Handok Inc. 30 participants Est. completion 2019-02-25 1 siteOther conditions: Diabete MellitusView official trial listing → -
Completed NCT NCT03784703
Type 2 Diabetic Patients Maintained on Statin Therapy
Not yet reported Damanhour University 160 participants Est. completion 2020-01-31 1 site Stand-aloneOther conditions: Dyslipidemia Associated With Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT03801733
Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin
Not yet reported Akebia Therapeutics 134 participants Est. completion 2018-11-24 1 site Stand-aloneOther conditions: Drug Interaction PotentiationView official trial listing → -
Terminated NCT NCT03820466
Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin
Not yet reported Dr. med. Mahir Karakas 68 participants Est. completion 2022-04-07 7 sites Stand-aloneOther conditions: Acute Chest SyndromeView official trial listing → -
Completed NCT NCT03830164
Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2022-11-02 1 site Stand-aloneOther conditions: Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE, ImpotenceView official trial listing → -
Completed NCT NCT03837925
Pharmaco-metabolomic Effects of Statins: METASTATINE
Not yet reported French Cardiology Society 120 participants Est. completion 2022-12-21 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03860220
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
Not yet reported Hyo-Soo Kim 252 participants Est. completion 2023-09-07 9 sitesOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT03867110
An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)
Not yet reported Organon and Co 628 participants Est. completion 2001-07-27 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03867318
Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)
Not yet reported Organon and Co 621 participants Est. completion 2001-11-16 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03867994
Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.
Not yet reported rabab ahmed mohamed 144 participants Est. completion 2017-05-15 Stand-aloneOther conditions: Contrast-induced NephropathyView official trial listing → -
Terminated NCT NCT03872388
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2023-10-19 5 sites Stand-aloneOther conditions: Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative, Inflammatory Breast Carcinoma, Progesterone Receptor Negative, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Triple-Negative Breast CarcinomaView official trial listing → -
Completed NCT NCT03874156
MUscle Side-Effects of Atorvastatin in Coronary Patients
Not yet reported Vestre Viken Hospital Trust 77 participants Est. completion 2019-12-12 2 sitesOther conditions: Statin Adverse ReactionView official trial listing → -
Status unknown NCT NCT03874260
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Not yet reported Daewon Pharmaceutical Co., Ltd. 180 participants Est. completion 2020-03-31 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT03877783
DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes
Not yet reported Umeå University 10 participants Est. completion 2023-06-30 1 site Stand-aloneType 2 diabetes Other conditions: Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT03882892
Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)
Not yet reported Organon and Co 400 participants Est. completion 2002-08-08 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03882996
A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)
Not yet reported Organon and Co 432 participants Est. completion 2003-02-04 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03884452
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)
Not yet reported Organon and Co 50 participants Est. completion 2001-05-24 Stand-aloneOther conditions: Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT03885921
Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)
Not yet reported Organon and Co 44 participants Est. completion 2003-07-08 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03906539
Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 150 participants Est. completion 2021-12-31 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03929744
A Study of LY3502970 in Healthy Participants
Not yet reported Eli Lilly and Company 133 participants Est. completion 2020-11-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT03943459
Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease
Not yet reported InCor Heart Institute 60 participants Est. completion 2022-06-30 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT03951207
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Not yet reported Yuhan Corporation 259 participants Est. completion 2021-09-29 1 siteOther conditions: Dyslipidemias, HypertensionView official trial listing → -
Status unknown NCT NCT03956368
Efficacy of Atorvastatin in Chronic Subdural Haematoma
Not yet reported Chinese University of Hong Kong 690 participants Est. completion 2023-03-16 7 sites Stand-aloneOther conditions: Chronic Subdural HematomaView official trial listing → -
Completed NCT NCT03966859
7-day Atorvastatin and Emotional Processing
Not yet reported University of Oxford 50 participants Est. completion 2020-02-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03967496
Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors
Sultan Qaboos University 402 participants Est. completion 2019-03-31 1 siteOther conditions: Delirium, Anesthesia; Adverse EffectView official trial listing → -
Status unknown NCT NCT03971019
Survival Benefits of Statins in Breast Cancer Patients
Not yet reported Peking Union Medical College Hospital 314 participants Est. completion 2024-06-28 1 site Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT04026230
Impact of Atorvastatin on Prostate Cancer Progression During ADT
Not yet reported Tampere University Hospital 400 participants Est. completion 2025-12-31 10 sites Stand-aloneOther conditions: Metastatic Prostate Cancer, Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT04047940
A Study of LY900020 in Healthy Chinese Participants
Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-02-18 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04056039
Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
Not yet reported Hospital Central "Dr. Ignacio Morones Prieto" 60 participants Est. completion 2019-06-30 1 siteCardiovascular disease Other conditions: Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT04061824
Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Terminated NCT NCT04072601
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
Not yet reported Copenhagen University Hospital, Hvidovre 78 participants Est. completion 2023-01-10 1 site Stand-aloneOther conditions: Liver CirrhosesView official trial listing → -
Completed NCT NCT04087382
Mechanical Thrombectomy in Acute Ischemic Stroke Beyond the Time of Window
Not yet reported Assiut University 57 participants Est. completion 2019-10-20 2 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04091412
Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion
Not yet reported The Second Hospital of Hebei Medical University 500 participants Est. completion 2020-05-01 1 site Stand-aloneOther conditions: Collateral Circulation, Large-artery Occlusion, Cerebral InfarctionView official trial listing → -
Status unknown NCT NCT04100434
Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome
Not yet reported Tianjin Chest Hospital 500 participants Est. completion 2023-06-01 1 site Stand-aloneOther conditions: Acute Coronary Syndrome, Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorView official trial listing → -
Status unknown NCT NCT04101136
Effect of Atorvastatin on Subclinical Atherosclerosis
Not yet reported Dr Cipto Mangunkusumo General Hospital 80 participants Est. completion 2021-07-15 1 siteOther conditions: CMVView official trial listing → -
Active, not recruiting NCT NCT04111419
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Not yet reported Shanghai Jiao Tong University School of Medicine 1200 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Atrial Fibrillation, HypertensionView official trial listing → -
Status unknown NCT NCT04148820
One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2021-10-31 2 sites Stand-aloneOther conditions: Ischemic Heart DiseaseView official trial listing → -
Status unknown NCT NCT04149483
Statin Treatment for UnruptureD Intracranial anEurysms Study
Not yet reported Beijing Neurosurgical Institute 60 participants Est. completion 2021-02-01 1 site Stand-aloneOther conditions: Intracranial Aneurysm, Inflammation VascularView official trial listing → -
Status unknown NCT NCT04151355
Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis
Not yet reported Ain Shams University 100 participants Est. completion 2020-09-30 1 site Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Status unknown NCT NCT04181749
Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography
Not yet reported University of Leicester 200 participants Est. completion 2024-01-31 3 sitesOther conditions: Cardiovascular Risk FactorView official trial listing → -
Status unknown NCT NCT04215237
How Atorvastatin Affects the Gut Flora and Metabolomics?
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 30 participants Est. completion 2021-06-01 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT04221321
Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers
Not yet reported HK inno.N Corporation 32 participants Est. completion 2020-04-20 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04245046
Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-02-18 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04251364
Treatment of Chronic Mountain Sickness
Not yet reported Centre d'Expertise sur l'Altitude EXALT 60 participants Est. completion 2021-12-30 1 site Stand-aloneOther conditions: Hypoxia, AltitudeView official trial listing → -
Completed NCT NCT04262765
Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin
Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-03-26 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04270370
A Study of LY3478045 in Healthy Participants
Not yet reported Eli Lilly and Company 72 participants Est. completion 2021-06-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04306627
Effect of Atorvastatin on Carotid Intima Media Thickness
Not yet reported Yerevan State Medical University 200 participants Est. completion 2021-02-28Other conditions: Essential Hypertension, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT04325009
Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"
Not yet reported Dong-A ST Co., Ltd. 56 participants Est. completion 2020-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT04333407
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
Not yet reported Imperial College London 320 participants Est. completion 2021-11-30 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04369664
CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
Not yet reported NYU Langone Health 151 participants Est. completion 2023-10-19 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04375787
Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention
Not yet reported Mohamed Abdelfatah 200 participants Est. completion 2020-06-02 1 siteOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT04379999
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Not yet reported Fox Chase Cancer Center 43 participants Est. completion 2025-08-04 1 siteOther conditions: Lynch SyndromeView official trial listing → -
Status unknown NCT NCT04380402
Atorvastatin as Adjunctive Therapy in COVID-19
Not yet reported Mount Auburn Hospital 300 participants Est. completion 2022-05-08 1 site Stand-aloneOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04388501
A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants
Not yet reported Janssen Pharmaceutica N.V., Belgium 23 participants Est. completion 2021-10-27 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04425590
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
Not yet reported, Not yet reported Duta Wacana Christian University 180 participants Est. completion 2020-08 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04434365
Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
Not yet reported, Not yet reported Peking Union Medical College Hospital 24 participants Est. completion 2020-12-30 1 siteCardiovascular disease Other conditions: Percutaneous Coronary InterventionView official trial listing → -
Completed NCT NCT04453735
MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study
Not yet reported Vestre Viken Hospital Trust 27 participants Est. completion 2020-12-18 2 sitesOther conditions: Statin Adverse ReactionView official trial listing → -
Status unknown NCT NCT04455581
A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 8 participants Est. completion 2021-08-31 Stand-aloneOther conditions: Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT04466241
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 294 participants Est. completion 2021-11-01 2 sites Stand-aloneOther conditions: COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2View official trial listing → -
Completed NCT NCT04472637
Atorvastatin Effects On Arterial Stiffness In Hemodialysis
Not yet reported Alexandria University 50 participants Est. completion 2021-07-01 1 site Stand-aloneOther conditions: Arterial StiffnessView official trial listing → -
Completed NCT NCT04486508
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
Not yet reported Rajaie Cardiovascular Medical and Research Center 600 participants Est. completion 2021-07-05 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Completed NCT NCT04511000
Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
Not yet reported Chong Kun Dang Pharmaceutical 250 participants Est. completion 2019-05-20 10 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Active, not recruiting NCT NCT04536870
Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study
Not yet reported Monash University 369 participants Est. completion 2026-12 2 sitesHeart failure Other conditions: Atrial Fibrillation, Healthy Ageing, Hypercholesterolemia, Myocardial DysfunctionView official trial listing → -
Active, not recruiting NCT NCT04575857
Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression
University of Washington 100 participants Est. completion 2040-02 1 siteOther conditions: Rheumatic Heart Disease, Valvular DiseaseView official trial listing → -
Status unknown NCT NCT04581759
Endovascular Treatment and RIPC in Acute Ischemic Stroke
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-10-30 1 siteCardiovascular disease Other conditions: Endovascular TreatmentView official trial listing → -
Terminated NCT NCT04591808
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
Not yet reported Institut de Recherches Internationales Servier 146 participants Est. completion 2022-04-08 43 sites Stand-aloneOther conditions: Dyslipidemias, HypertensionView official trial listing → -
Status unknown NCT NCT04607447
Low Intracranial Pressure Treatment Strategies for Chronic Subdural Hematoma Patients
Not yet reported Huashan Hospital 160 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Chronic Subdural HematomaView official trial listing → -
Completed NCT NCT04608344
Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants
Not yet reported Gilead Sciences 27 participants Est. completion 2021-01-13 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04626973
Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04631536
Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC
Not yet reported Lebanese American University Medical Center 42 participants Est. completion 2022-07-01 1 site Stand-aloneOther conditions: Covid19View official trial listing → -
Active, not recruiting NCT NCT04656028
Genetic Testing and Motivational Counseling for FH
Not yet reported National Medical Research Center for Therapy and Preventive Medicine 180 participants Est. completion 2025-03-30 1 site Stand-aloneOther conditions: Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2, Hypercholesterolemia, Familial, 3, Hypercholesterolemia, Familial, 4, Hypercholesterolemia, Familial, 4, Autosomal Recessive, Familial Hypercholesterolemia With Hyperlipemia, Hypercholesterolemia, Autosomal Dominant, Type B, Hypercholesterolemia, Autosomal Dominant, Hypercholesterolemia, Autosomal Dominant, 3, Apolipoprotein B-100, Familial Defective, Genetic Testing, Motivational Interviewing, Therapeutic Adherence, Therapeutic Adherence and Compliance, Treatment Adherence, Medication Adherence, Treatment Adherence and Compliance, Patient Adherence, Compliance, Patient Compliance, Familial Hypercholesterolemia, Familial Hypercholesterolemia - Heterozygous, Adherence, Patient, Adherence, Medication, AdherenceView official trial listing → -
Status unknown NCT NCT04661709
Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 502 participants Est. completion 2023-06-01 Stand-aloneOther conditions: Coronary Heart Disease, Unstable Angina, Chinese Herbal MedicineView official trial listing → -
Completed NCT NCT04666389
The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases
Not yet reported I.M. Sechenov First Moscow State Medical University 150 participants Est. completion 2023-01-10 1 siteCardiovascular disease Other conditions: Contrast-induced Acute Kidney InjuryView official trial listing → -
Active, not recruiting NCT NCT04679376
Statins for the Treatment of NASH
Not yet reported Mayo Clinic 70 participants Est. completion 2026-12 2 sites Stand-aloneMASHView official trial listing → -
Status unknown NCT NCT04685642
Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model
Not yet reported Taipei Veterans General Hospital, Taiwan 180 participants Est. completion 2023-07-31 1 siteOther conditions: Mood DisorderView official trial listing → -
Status unknown NCT NCT04701242
Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
Not yet reported Cairo University 500 participants Est. completion 2025-12 1 siteCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT04718155
Could Early Atorvastatin Offer Anti Inflammatory Effects Upon Brain in Traumatic Head Injury?
Not yet reported Assiut University 30 participants Est. completion 2022-06-01 1 siteOther conditions: Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT04721795
Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
Not yet reported, Not yet reported Obafemi Awolowo University Teaching Hospital 150 participants Est. completion 2022-06-30 2 sites Stand-aloneOther conditions: Tuberculosis, Pulmonary, TuberculosisView official trial listing → -
Status unknown NCT NCT04737408
Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
Not yet reported Bjarne Linde Noergaard 120 participants Est. completion 2023-08 3 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04744571
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
Not yet reported Beijing Anzhen Hospital 200 participants Est. completion 2023-01 1 site Stand-aloneCardiovascular disease Other conditions: Coronary Occlusion, Percutaneous Coronary Intervention, Chronic Total Occlusion of Coronary Artery, Drug-Eluting StentsView official trial listing → -
Completed NCT NCT04747847
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
Not yet reported University of California, San Diego 5 participants Est. completion 2022-08-17 1 site Stand-aloneOther conditions: Kawasaki DiseaseView official trial listing → -
Status unknown NCT NCT04754789
Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
Not yet reported Assiut University 160 participants Est. completion 2021-03-01Cardiovascular diseaseView official trial listing → -
Terminated NCT NCT04764851
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 siteOther conditions: Drug-InteractionsView official trial listing → -
Active, not recruiting NCT NCT04767984
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Not yet reported Northwestern University 42 participants Est. completion 2026-11-30 3 sites Stand-aloneOther conditions: Colorectal Carcinoma, Ulcerative ColitisView official trial listing → -
Active, not recruiting NCT NCT04789057
Atorvastatin Effect on Reduction of COPD Exacerbations
Not yet reported Medical University of Bialystok 460 participants Est. completion 2027-05-31 1 site Stand-aloneOther conditions: Copd, COPD Exacerbation, Smoking, Gene Expression, AtorvastatinView official trial listing → -
Status unknown NCT NCT04801940
HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)
Not yet reported Cambridge University Hospitals NHS Foundation Trust 2631 participants Est. completion 2024-01-31 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04813471
Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH
Not yet reported Lebanese American University Medical Center 70 participants Est. completion 2021-04-30 1 site Stand-aloneOther conditions: Covid19, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT04824911
Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
Not yet reported Chang Gung Memorial Hospital 376 participants Est. completion 2025-02-28 1 site Stand-aloneCardiovascular disease Other conditions: Dual Antiplatelet Therapy, StatinView official trial listing → -
Completed NCT NCT04829149
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
Hanmi Pharmaceutical Company Limited 5717 participants Est. completion 2019-08-29 1 siteOther conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT04850001
Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study
Anhui Medical University 40 participants Est. completion 2025-12-31 1 siteOther conditions: Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis, Medical TreatmentView official trial listing → -
Completed NCT NCT04851769
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography
Not yet reported Beijing Anzhen Hospital 60 participants Est. completion 2021-03-01 1 site Stand-aloneOther conditions: Randomized Controlled TrialsView official trial listing → -
Status unknown NCT NCT04857632
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
Not yet reported, Not yet reported Capital Medical University 98 participants Est. completion 2024-11-30 3 sites Stand-aloneOther conditions: Intracerebral Hemorrhage, StatinsView official trial listing → -
Active, not recruiting NCT NCT04862260
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
Not yet reported CHU de Quebec-Universite Laval 3 participants Est. completion 2026-12-31 2 sites Stand-aloneOther conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer, Metastatic CancerView official trial listing → -
Completed NCT NCT04863274
Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance
The League of Clinical Research, Russia 2912 participants Est. completion 2020-10-15 1 siteOther conditions: Lipid Metabolism DisordersView official trial listing → -
Status unknown NCT NCT04882293
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Not yet reported Laboratorios Silanes S.A. de C.V. 78 participants Est. completion 2022-05 1 site Stand-aloneOther conditions: Dyslipidemia Associated With Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT04895098
Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD
Akrikhin 1000 participants Est. completion 2022-07-08 31 sitesCardiovascular disease Other conditions: Lipid Metabolism DisordersView official trial listing → -
Status unknown NCT NCT04900155
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
Not yet reported Penza State University 45 participants Est. completion 2024-12 1 siteOther conditions: STEMI, Covid19, NSTEMIView official trial listing → -
Active, not recruiting NCT NCT04904536
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
Not yet reported The George Institute 190 participants Est. completion 2025-07-30 1 site Stand-aloneOther conditions: Neurocognitive Impairment, MildView official trial listing → -
Withdrawn NCT NCT04922424
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
Not yet reported Yale University Est. completion 2023-08-31 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Status unknown NCT NCT04925219
REmotely Supervised Exercise Therapy Trial 2
Not yet reported Mid and South Essex NHS Foundation Trust 40 participants Est. completion 2024-12 1 site Stand-aloneAlcohol use disorder Other conditions: Peripheral Arterial DiseaseView official trial listing → -
Status unknown NCT NCT04943783
Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms
Not yet reported Beijing Neurosurgical Institute 40 participants Est. completion 2022-07-30 2 sites Stand-aloneOther conditions: Dissecting Aneurysm of Cerebral Artery, Intramural Hematomas, Inflammation VascularView official trial listing → -
Status unknown NCT NCT04945122
Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 900 participants Est. completion 2023-12-31 1 siteCardiovascular disease Other conditions: Glucose Metabolism DisordersView official trial listing → -
Status unknown NCT NCT04952350
Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT
Not yet reported Mansoura University 220 participants Est. completion 2022-04 1 siteOther conditions: Covid19, SARS-CoV2 Infection, COVID-19 PneumoniaView official trial listing → -
Completed NCT NCT04972396
Pemvidutide (ALT-801) DDI Study in Healthy Volunteers
Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sites Stand-aloneMASHView official trial listing → -
Status unknown NCT NCT04974814
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
Not yet reported Beni-Suef University 99 participants Est. completion 2023-04 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT04984616
Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
Not yet reported Juan D. Maya 300 participants Est. completion 2024-04-01 4 sites Stand-aloneOther conditions: Chronic Chagas DiseaseView official trial listing → -
Not yet recruiting NCT NCT05049603
A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study
Not yet reported University of Pisa 102 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Graves' OrbitopathyView official trial listing → -
Status unknown NCT NCT05072054
Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 80 participants Est. completion 2022-08-31 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT05093205
STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
Not yet reported Pfizer 35 participants Est. completion 2022-07-06 1 site Stand-aloneOther conditions: Healthy AdultsView official trial listing → -
Status unknown NCT NCT05103644
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
Not yet reported, Not yet reported Beni-Suef University 60 participants Est. completion 2024-12-30 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05122780
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120 participants Est. completion 2025-07 3 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT05131997
A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A
Not yet reported Addpharma Inc. 290 participants Est. completion 2022-06-08 1 siteOther conditions: Primary HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT05165251
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
Not yet reported Shanghai Jiao Tong University School of Medicine 480 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Isolated Systolic HypertensionView official trial listing → -
Completed NCT NCT05238012
Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
Not yet reported Heart Health Research Center 392 participants Est. completion 2024-04-02 1 siteOther conditions: Metabolism Disorder, Lipid, Metabolism Disorder, GlucoseView official trial listing → -
Completed NCT NCT05250596
COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
Not yet reported Azienda USL Toscana Centro 182 participants Est. completion 2024-05-30 3 sites Stand-aloneOther conditions: Non ST Segment Elevation Acute Coronary SyndromeView official trial listing → -
Withdrawn NCT NCT05251129
Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation
Not yet reported Montefiore Medical Center Est. completion 2030-06 Stand-aloneOther conditions: VasculopathyView official trial listing → -
Completed NCT NCT05285085
Real World Evidence Study of Statin Use in Brazil
Hospital Israelita Albert Einstein 2133900 participants Est. completion 2021-12-15 1 siteCardiovascular disease Other conditions: Hypertension, Diabetes Mellitus, DyslipidemiasView official trial listing → -
Status unknown NCT NCT05298475
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
Not yet reported The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2024-04-01 1 site Stand-aloneOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT05306990
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
Not yet reported Helwan University 108 participants Est. completion 2021-01-31 1 siteOther conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes MellitusView official trial listing → -
Completed NCT NCT05327595
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Eli Lilly and Company 80 participants Est. completion 2024-04-22 1 site Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT05331053
MicroRNA Activation of LOX-1 Mechanisms in Endometriosis
Not yet reported Penn State University 6 participants Est. completion 2024-08-31 1 site Stand-aloneOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT05334108
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport
Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT05342974
Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
Not yet reported University of Utah 9 participants Est. completion 2025-01-06 1 site Stand-aloneOther conditions: Abortion EarlyView official trial listing → -
Active, not recruiting NCT NCT05361421
Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial
Not yet reported Yonsei University 1200 participants Est. completion 2027-10-15 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05368545
Influence of Lipid Lowering on Impaired Coronary Flow
Not yet reported Aarhus University Hospital 109 participants Est. completion 2024-04-17 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT05372380
A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers
Not yet reported Boryung Pharmaceutical Co., Ltd 32 participants Est. completion 2022-06-30 1 siteOther conditions: Hypertension, HypercholesterinemiaView official trial listing → -
Status unknown NCT NCT05395143
Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 92 participants Est. completion 2022-07-10 1 site Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Status unknown NCT NCT05398393
An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150 participants Est. completion 2023-06-30 1 siteOther conditions: Hepatitis B, Chronic, Lipid DisorderView official trial listing → -
Active, not recruiting NCT NCT05462262
Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 2900 participants Est. completion 2029-08 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05464628
Drug Interaction Study of ASC42 With Atorvastatin
Not yet reported Gannex Pharma Co., Ltd. 12 participants Est. completion 2022-08-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05479097
Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage
Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2023-12-31 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT05483894
Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
Not yet reported Samsung Medical Center 36 participants Est. completion 2025-01-31Other conditions: Hepatitis B, Portal HypertensionView official trial listing → -
Completed NCT NCT05488067
Atorvastatin Therapy on Xanthoma in Alagille Syndrome
Not yet reported Children's Hospital of Fudan University 15 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Alagille Syndrome, Atorvastatin, XanthomaView official trial listing → -
Status unknown NCT NCT05504330
Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients
Anhui Medical University 100 participants Est. completion 2025-12-31 1 siteOther conditions: Asymptomatic Intracranial Stenosis, Cognitive Impairment, Cerebrovascular EventView official trial listing → -
Status unknown NCT NCT05507398
The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
Not yet reported Tanta University 100 participants Est. completion 2023-09Other conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT05511766
Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis
Not yet reported, Not yet reported Tanta University 150 participants Est. completion 2026-01-25 1 siteOther conditions: Cirrhosis, Hepatic Encephalopathy, Ascites, Varices, SBP - Spontaneous Bacterial PeritonitisView official trial listing → -
Completed NCT NCT05551624
Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine
Not yet reported Hospital Civil de Guadalajara 15 participants Est. completion 2020-01-23 1 site Stand-aloneOther conditions: Primary Immune ThrombocytopeniaView official trial listing → -
Completed NCT NCT05555238
An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
Hanmi Pharmaceutical Company Limited 1716 participants Est. completion 2022-01-27 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT05559606
An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Boryung Pharmaceutical Co., Ltd 1839 participants Est. completion 2025-07-30 1 siteOther conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT05561062
Atorvastatin in Patients With Ulcerative Colitis
Not yet reported Tanta University 50 participants Est. completion 2024-11-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT05563389
Statin Impact on Hepatic Decompensation
Not yet reported, Not yet reported Tanta University 100 participants Est. completion 2023-02-25 1 siteOther conditions: Quality of Life, the Incidence of Whole Complications Resultant From Decompensated LiverView official trial listing → -
Status unknown NCT NCT05565976
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
Not yet reported, Not yet reported Jaime Daniel Mondragon 270 participants Est. completion 2025-07-01 1 site Stand-aloneCardiovascular diseaseMetabolic syndrome Other conditions: Mild Cognitive Impairment, Dementia, VascularView official trial listing → -
Completed NCT NCT05567068
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
Not yet reported Tanta University 54 participants Est. completion 2025-06-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT05583643
Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment
Not yet reported Misr University for Science and Technology 24 participants Est. completion 2022-06-30 1 siteOther conditions: PeriodontitisView official trial listing → -
Status unknown NCT NCT05585151
High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200 participants Est. completion 2024-10-01 1 siteOther conditions: Cerebral AtherosclerosisView official trial listing → -
Active, not recruiting NCT NCT05586750
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
Not yet reported Monash University 341 participants Est. completion 2026-09 2 sites Stand-aloneOther conditions: Dementia, Mixed, Dementia, Vascular, Dementia of Alzheimer Type, Cognitive Decline, White Matter Hyperintensity, Aging, Neuro-Degenerative DiseaseView official trial listing → -
Not yet recruiting NCT NCT05589454
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
Not yet reported Sichuan Provincial People's Hospital 344 participants Est. completion 2027-06 5 sites Stand-aloneCardiovascular disease Other conditions: Cerebral MicrobleedsView official trial listing → -
Status unknown NCT NCT05620615
Intensive Drug Therapy for Ischemic Stroke
Shanghai Yueyang Integrated Medicine Hospital 42 participants Est. completion 2023-12-01 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05624658
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
Not yet reported Samara Regional Cardiology Dispensary 200 participants Est. completion 2024-05 1 siteOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT05642845
Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions
Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-06-05 1 siteOther conditions: BioequivalenceView official trial listing → -
Status unknown NCT NCT05675787
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Not yet reported Peking University People's Hospital 82 participants Est. completion 2025-10-31 1 site Stand-aloneOther conditions: Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage IView official trial listing → -
Completed NCT NCT05679102
Atorvastatin as an Antihypertensive Agent
Not yet reported Himayat Ullah 120 participants Est. completion 2023-01-04 1 siteOther conditions: Atorvastatin Antihypertensive EffectView official trial listing → -
Completed NCT NCT05681273
Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Not yet reported Chipscreen Biosciences, Ltd. 48 participants Est. completion 2023-03-21 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT05697185
Safety and Efficacy of Evolocumab in Ischemic Stroke
Not yet reported Second Affiliated Hospital of Guangxi Medical University 200 participants Est. completion 2024-12-01 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05730634
The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24 participants Est. completion 2022-05-06 1 site Stand-aloneType 2 diabetes Other conditions: Vascular InflammationView official trial listing → -
Status unknown NCT NCT05741086
Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)
Not yet reported The First Affiliated Hospital with Nanjing Medical University 80 participants Est. completion 2024-08-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05747768
A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
Not yet reported Peking University Third Hospital 60 participants Est. completion 2024-12-31 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT05761444
Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
Not yet reported Organon and Co 137 participants Est. completion 2024-10-15 7 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05764317
Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)
Servier Russia 409 participants Est. completion 2024-02-20 1 siteOther conditions: Arterial Hypertension, HTNView official trial listing → -
Completed NCT NCT05790499
LDL-c Level Variability and Trained Immunity
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 11 participants Est. completion 2025-04-03 1 site Stand-aloneOther conditions: Cholesterol Variability, Trained ImmunityView official trial listing → -
Status unknown NCT NCT05792293
Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity
Not yet reported, Not yet reported Ain Shams University 100 participants Est. completion 2023-06 1 site Stand-aloneOther conditions: Doxorubicin Induced CardiomyopathyView official trial listing → -
Completed NCT NCT05792540
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Not yet reported Tanta University 75 participants Est. completion 2024-12-20 1 siteOther conditions: Depressive DisorderView official trial listing → -
Completed NCT NCT05806723
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Not yet reported Hopital La Rabta 104 participants Est. completion 2022-09-15 1 site Stand-aloneType 2 diabetes Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus, Statin Adverse Reaction, Hypogonadism, Male, Adrenal Insufficiency, Vitamin D DeficiencyView official trial listing → -
Status unknown NCT NCT05812404
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
Not yet reported Daewoong Pharmaceutical Co. LTD. 36 participants Est. completion 2023-06-16 1 site Stand-aloneOther conditions: Drug Drug InteractionView official trial listing → -
Status unknown NCT NCT05814692
BIOchemical Urine Analysis of Adherence to Statins and Associated FACTorS in Coronary Artery Disease
Heinrich-Heine University, Duesseldorf 130 participants Est. completion 2024-09 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT05815680
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Not yet reported Innovent Biologics (Suzhou) Co. Ltd. 48 participants Est. completion 2023-10-30 1 site Stand-aloneOther conditions: Overweight Subjects, Obese SubjectsView official trial listing → -
Enrolling by invitation NCT NCT05826912
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Not yet reported University of California, San Francisco 672 participants Est. completion 2029-08-31 18 sitesOther conditions: Traumatic Brain InjuryView official trial listing → -
Status unknown NCT NCT05839236
COVID-19 Vaccination Detoxification in LDL-C
Not yet reported Yang I. Pachankis 1 participants Est. completion 2023-07-31 1 site Stand-aloneCardiovascular disease Other conditions: COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism, COVID-19 Post-Intensive Care Syndrome, COVID-19 Respiratory InfectionView official trial listing → -
Completed NCT NCT05845580
Patient Autonomy and Statin Therapy Adherence
Not yet reported Lithuanian University of Health Sciences 300 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Drug AdherenceView official trial listing → -
Enrolling by invitation NCT NCT05870007
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Not yet reported Taipei Medical University Shuang Ho Hospital 30 participants Est. completion 2026-12 3 sitesChronic kidney disease Other conditions: Autosomal Dominant Polycystic Kidney DiseaseView official trial listing → -
Completed NCT NCT05877235
Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:
Not yet reported InCor Heart Institute 60 participants Est. completion 2024-06-23 1 site Stand-aloneCardiovascular disease Other conditions: MenopauseView official trial listing → -
Status unknown NCT NCT05893849
Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
Peking University Third Hospital 624 participants Est. completion 2024-04 1 siteOther conditions: AgingView official trial listing → -
Completed NCT NCT05895123
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
Not yet reported Damanhour University 80 participants Est. completion 2023-04-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT05910476
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
Not yet reported Yonsei University 200 participants Est. completion 2026-09-22 1 siteCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT05912686
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
Not yet reported Zhongda Hospital 162 participants Est. completion 2026-07-31 1 siteCardiovascular disease Other conditions: Mechanical ThrombectomyView official trial listing → -
Status unknown NCT NCT05925140
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sites Stand-aloneOther conditions: COVID-19, Hospitalized COVID-19 PatientsView official trial listing → -
Completed NCT NCT05930028
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Not yet reported Boryung Pharmaceutical Co., Ltd 148 participants Est. completion 2024-09-05 1 site Stand-aloneOther conditions: Essential Hypertension, Primary HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT05933720
Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
Not yet reported Ryazan State Medical University 120 participants Est. completion 2026-09-01 1 siteOther conditions: Peripheral Arterial Occlusive DiseaseView official trial listing → -
Status unknown NCT NCT05946122
Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index
Not yet reported Minia University 106 participants Est. completion 2023-12-30 1 siteOther conditions: Renal ProtectionView official trial listing → -
Completed NCT NCT05970679
Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A
Not yet reported Daewon Pharmaceutical Co., Ltd. 252 participants Est. completion 2023-04-13 1 site Stand-aloneOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Status unknown NCT NCT05976893
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
Not yet reported Xiang Xie 620 participants Est. completion 2025-12-31 Stand-aloneCardiovascular disease Other conditions: Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor, CancerView official trial listing → -
Completed NCT NCT05996978
Intensive Drug Therapy for Ischemic Stroke Caused by Severe Intracranial Arterial Stenosis
Shanghai Yueyang Integrated Medicine Hospital 42 participants Est. completion 2023-04-30 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT06024096
Systems Biological Assessment of Statin Effect on Vaccine Responses
Not yet reported Emory University 63 participants Est. completion 2024-12-16 1 siteOther conditions: Vaccine ResponseView official trial listing → -
Status unknown NCT NCT06052020
Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
The First Affiliated Hospital with Nanjing Medical University 50 participants Est. completion 2024-09-30 1 siteCardiovascular disease Other conditions: Intracranial Atherosclerotic StenosisView official trial listing → -
Completed NCT NCT06053983
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Not yet reported Rawalpindi Medical College 126 participants Est. completion 2023-08-01 1 site Stand-aloneOther conditions: Mi Q WaveView official trial listing → -
Status unknown NCT NCT06080256
Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
Not yet reported The First Affiliated Hospital with Nanjing Medical University 80 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Intracranial Atherosclerosis, Atherosclerotic Plaque, StenosisView official trial listing → -
Completed NCT NCT06081166
A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Not yet reported NewAmsterdam Pharma 74 participants Est. completion 2024-01-22 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT06083337
Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography
Not yet reported Hippocration General Hospital 140 participants Est. completion 2025-07-22 1 site Stand-aloneCardiovascular disease Other conditions: Atheroscleroses, Coronary, Vascular InflammationView official trial listing → -
Completed NCT NCT06094244
Statins in Patients With Spontaneous Intracerebral Hemorrhage
Not yet reported Pomeranian Medical University Szczecin 153 participants Est. completion 2021-03-17 1 site Stand-aloneOther conditions: Intracerebral HemorrhageView official trial listing → -
Not yet recruiting NCT NCT06096909
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Not yet reported China National Center for Cardiovascular Diseases 3684 participants Est. completion 2027-11-01 Stand-aloneOther conditions: Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary SyndromeView official trial listing → -
Not yet recruiting NCT NCT06112028
Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting
Not yet reported Yanbin Li 200 participants Est. completion 2026-11 Stand-aloneOther conditions: Stent RestenosisView official trial listing → -
Status unknown NCT NCT06134635
Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke
Xuanwu Hospital, Beijing 80 participants Est. completion 2024-12-01Cardiovascular diseaseView official trial listing → -
Completed NCT NCT06139952
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Not yet reported Ain Shams University 120 participants Est. completion 2024-07-01 1 site Stand-aloneCardiovascular disease Other conditions: Nephropathy; Toxic, DrugsView official trial listing → -
Status unknown NCT NCT06140095
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
Not yet reported Region Stockholm 8 participants Est. completion 2025-12 Stand-aloneOther conditions: Acute Metabolic Effects of Evolocumab and AtorvastatinView official trial listing → -
Active, not recruiting NCT NCT06157099
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma
Not yet reported OHSU Knight Cancer Institute 150 participants Est. completion 2029-09-01 1 site Stand-aloneOther conditions: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIB Cutaneous Melanoma AJCC v8View official trial listing → -
Completed NCT NCT06191991
A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Not yet reported Aligos Therapeutics 14 participants Est. completion 2023-12-04 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT06208384
Topical Statin Eye Drop in the Management of the Dry Eye
Not yet reported, Not yet reported Shahid Beheshti University of Medical Sciences 20 participants Est. completion 2025-02-04 1 site Stand-aloneOther conditions: Dry Eye DiseaseView official trial listing → -
Status unknown NCT NCT06239714
A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Not yet reported Suzhou Sanegene Bio Inc. 64 participants Est. completion 2025-05-30 Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT06241352
Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
Not yet reported Changhai Hospital 42 participants Est. completion 2025-04-30 1 site Stand-aloneOther conditions: Advanced Pancreatic CancerView official trial listing → -
Status unknown NCT NCT06262685
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Not yet reported Instituto de Investigación Hospital Universitario La Paz 216 participants Est. completion 2025-03-04 1 site Stand-aloneCardiovascular disease Other conditions: Dyslipidemias, Statin Adverse Reaction, Pharmacogenic MyopathyView official trial listing → -
Status unknown NCT NCT06273215
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Not yet reported Peking University Third Hospital 48 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Withdrawn NCT NCT06280976
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Not yet reported University of Louisville Est. completion 2025-01-01 1 site Stand-aloneCardiovascular disease Other conditions: Atherosclerosis, Heart AttackView official trial listing → -
Status unknown NCT NCT06286059
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
Not yet reported, Not yet reported Helwan University 60 participants Est. completion 2025-01-31 1 siteCardiovascular disease Other conditions: CA-AKI - Contrast-Associated Acute Kidney Injury, Acute Coronary Syndrome, Adrenergic Receptor Antagonist Adverse ReactionView official trial listing → -
Completed NCT NCT06289504
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Not yet reported Novo Nordisk A/S 34 participants Est. completion 2024-11-15 1 site Added to GLP-1Other conditions: ObesityView official trial listing → -
Completed NCT NCT06293742
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Not yet reported Eccogene 48 participants Est. completion 2024-04-15 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT06364124
Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
Not yet reported Beijing Luhe Hospital 84 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: STEMIView official trial listing → -
Enrolling by invitation NCT NCT06369571
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Not yet reported, Not yet reported Johns Hopkins University 22 participants Est. completion 2027-12 1 siteOther conditions: Epilepsy, DyslipidemiaView official trial listing → -
Active, not recruiting NCT NCT06372925
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
Not yet reported Novartis Pharmaceuticals 318 participants Est. completion 2027-01-26 19 sites Stand-aloneOther conditions: Plaque, AtheroscleroticView official trial listing → -
Status unknown NCT NCT06382974
Evaluation of the Osteoinductivity of Atorvastatin Combined With β-TCP
Not yet reported Cairo University 10 participants Est. completion 2026-03 1 site Stand-aloneOther conditions: Infection, Bone LossView official trial listing → -
Completed NCT NCT06403787
Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment
Not yet reported, Not yet reported University of Guadalajara 28 participants Est. completion 2024-04-01 1 siteOther conditions: Human Immunodeficiency VirusView official trial listing → -
Status unknown NCT NCT06422650
Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 84 participants Est. completion 2024-08-31 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Status unknown NCT NCT06469450
KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts
Not yet reported Mikko Niemi 15 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: PharmacodynamicsView official trial listing → -
Completed NCT NCT06545461
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
Not yet reported Donald Wesson 108 participants Est. completion 2016-10-30 Stand-aloneChronic kidney diseaseCardiovascular disease Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT06551298
Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink
Not yet reported The First Affiliated Hospital with Nanjing Medical University 129 participants Est. completion 2025-08-08 1 siteOther conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT06553157
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Not yet reported, Not yet reported Minia University 56 participants Est. completion 2025-10-01 1 site Stand-aloneOther conditions: Solid Tumors, OtotoxicityView official trial listing → -
Withdrawn NCT NCT06559072
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
Not yet reported The George Institute Est. completion 2026-09-01 1 site Stand-aloneOther conditions: Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal, Aneurysmal Subarachnoid Hemorrhage, Hemorrhage, Aneurysmal SubarachnoidView official trial listing → -
Completed NCT NCT06567327
A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese
Not yet reported Pfizer 82 participants Est. completion 2025-04-14 3 sites Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT06601517
A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.
Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30 participants Est. completion 2025-04 1 site Stand-aloneOther conditions: Healthy Adult Subject, Overweight SubjectView official trial listing → -
Completed NCT NCT06615284
A Study of Atorvo+™ in Healthy Adult Participants
Not yet reported Indication Bioscience LLC 24 participants Est. completion 2025-06-10 1 site Stand-aloneOther conditions: Coronary Heart Disease, DyslipidemiasView official trial listing → -
Completed NCT NCT06642740
Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia
Beijing Ditan Hospital 108 participants Est. completion 2025-06-01 1 siteOther conditions: Chronic Liver Disease, ThrombopeniaView official trial listing → -
Completed NCT NCT06674044
Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population
Riphah International University 100 participants Est. completion 2024-08-31 1 siteOther conditions: HyperlipidemiasView official trial listing → -
Active, not recruiting NCT NCT06684366
Chronic Coronary Syndrome Real Practice and Guidelines
Assiut University 300 participants Est. completion 2025-10-22 1 siteOther conditions: Coronary Arterial Disease (CAD)View official trial listing → -
Not yet recruiting NCT NCT06684509
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Not yet reported, Not yet reported Assiut University 46 participants Est. completion 2029-09 1 siteOther conditions: Leukemia, Hodgkin DiseaseView official trial listing → -
Active, not recruiting NCT NCT06686615
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2000 participants Est. completion 2028-01-31 163 sitesOther conditions: Primary Hypercholesterolemiia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT06696820
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Not yet reported, Not yet reported Xiang Luo 429 participants Est. completion 2026-06-03 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT06699355
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2023-12-29 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06723691
Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects
Not yet reported Fujian Shengdi Pharmaceutical Co., Ltd. 57 participants Est. completion 2025-06-09 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT06782243
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome
Not yet reported Khyber Medical University Peshawar 190 participants Est. completion 2025-08-25 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Not yet recruiting NCT NCT06785727
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
Not yet reported Prof. dr. Nathalie van der Velde 612 participants Est. completion 2029-07-01 Stand-aloneCardiovascular disease Other conditions: Transient Ischemic AttackView official trial listing → -
Not yet recruiting NCT NCT06785974
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
Not yet reported Erasmus Medical Center 140 participants Est. completion 2030-02 1 site Stand-aloneOther conditions: Atherosclerosis, Melanoma, Immune-related Adverse EventView official trial listing → -
Withdrawn NCT NCT06789432
Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population
Not yet reported Dr. Md. Alimur Reza Est. completion 2025-12 1 site Stand-aloneOther conditions: Hyperlipidemia (E.G., Hypercholesterolemia)View official trial listing → -
Not yet recruiting NCT NCT06791031
PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)
Not yet reported West China Hospital 212 participants Est. completion 2028-06 Stand-aloneCardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT06796660
Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients
Not yet reported Liu Zhanghong 70 participants Est. completion 2027-12-31 3 sites Stand-aloneOther conditions: Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT06841536
Combined Effects of Statins and Exercise on Training Sensitive Health Markers
Not yet reported University of the Faroe Islands 120 participants Est. completion 2026-01-30 1 siteOther conditions: DyslipidemiasView official trial listing → -
Not yet recruiting NCT NCT06856772
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
Not yet reported Tor Biering-Sørensen 42000 participants Est. completion 2028-03-28 1 site Stand-aloneCardiovascular disease Other conditions: Drug EffectView official trial listing → -
Completed NCT NCT06866509
To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
Daewoong Pharmaceutical Co. LTD. 3000 participants Est. completion 2024-02-28 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT06871358
The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients
Not yet reported Universitas Sebelas Maret 40 participants Est. completion 2024-11-20 1 siteOther conditions: STEMI (STE-ACS), Primary PCI for STEMIView official trial listing → -
Active, not recruiting NCT NCT06924684
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Not yet reported Sheikh Zayed Federal Postgraduate Medical Institute 66 participants Est. completion 2025-07-02 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT06948747
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
Not yet reported AstraZeneca 49 participants Est. completion 2025-10-03 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Not yet recruiting NCT NCT06974084
A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Not yet reported, Not yet reported HealthBio, Inc. 252 participants Est. completion 2027-05 1 siteOther conditions: Long COVIDView official trial listing → -
Active, not recruiting NCT NCT06976866
Effect of Topical Application of Atorvastatin Gel Versus Hyaluronic Acid on Immediate Loading Dental Implant in Posterior Maxilla
Not yet reported Amira attia 21 participants Est. completion 2025-05-14 1 site Stand-aloneOther conditions: In Recent Years, There Has Been a Rise in the Use of Immediate Loading Protocols, Dental Implant StabilityView official trial listing → -
Completed NCT NCT07008794
Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs
Assiut University 200 participants Est. completion 2023-03-31 1 siteOther conditions: Acute Coronary SyndromesView official trial listing → -
Active, not recruiting NCT NCT07042165
Treatment of Bile Acid Diarrhoea With Atorvastatin
Not yet reported Asger Lund, MD 20 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Bile Acid Diarrhea, Bile Acid MalabsorptionView official trial listing → -
Not yet recruiting NCT NCT07087379
Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT)
Not yet reported Pan Xiangbin 500 participants Est. completion 2028-01-01 Stand-aloneOther conditions: Aortic Stenosis, Cerebral Ischaemic InjuryView official trial listing → -
Not yet recruiting NCT NCT07088523
Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study
Not yet reported Guangzhou University of Traditional Chinese Medicine 4205 participants Est. completion 2027-12-31 1 siteCardiovascular disease Other conditions: Diabete MellitusView official trial listing → -
Not yet recruiting NCT NCT07121088
Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
Not yet reported Guangzhou University of Traditional Chinese Medicine 3666 participants Est. completion 2027-12-31Other conditions: Ischemic Cerebral Infarction, Diabetes MellitusView official trial listing → -
Completed NCT NCT07128212
Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1
Not yet reported Suzhou Municipal Hospital of Anhui Province 401 participants Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Ischemic White Matter Lesions (WMIL), Cerebral Small Vessel Disease, Vascular Cell Adhesion Molecule-1, VCAM-1View official trial listing → -
Completed NCT NCT07148037
Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population
Riphah International University 150 participants Est. completion 2025-07-31 1 siteOther conditions: HyperlipidemiasView official trial listing → -
Not yet recruiting NCT NCT07180745
Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease
Not yet reported Badr University 400 participants Est. completion 2026-03-01 1 siteMASLDMASHView official trial listing → -
Not yet recruiting NCT NCT07197463
The Therapeutic Effect of Phase I Cardiac Rehabilitation on Elderly Patients With CHD Complicated by Sarcopenia
Not yet reported Qilu Hospital of Shandong University 100 participants Est. completion 2026-11-10 Stand-aloneOther conditions: Coronary Disease, SarcopeniaView official trial listing → -
Completed NCT NCT07235189
A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin
Not yet reported Daiichi Sankyo 58 participants Est. completion 2026-01-28 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT07268625
Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin
Not yet reported Daiichi Sankyo 58 participants Est. completion 2026-02-24 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT07278830
A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia
Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 214 participants Est. completion 2024-06-07 1 site Stand-aloneOther conditions: Hypercholesterolemia and Mixed DyslipidemiaView official trial listing → -
Not yet recruiting NCT NCT07290699
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Not yet reported Second Affiliated Hospital of Nanchang University 2442 participants Est. completion 2028-08-30 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT07301372
Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
Not yet reported The Affiliated Hospital of Xuzhou Medical University 132 participants Est. completion 2026-06-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT07362030
Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
Not yet reported Guangdong Raynovent Biotech Co., Ltd 32 participants Est. completion 2026-03-30 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Completed NCT NCT07378228
Weak Pulse at Yang and Wiry Pulse at Yin Theory
Not yet reported Xikun Li 70 participants Est. completion 2024-06-01 1 site Stand-aloneOther conditions: Coronary Heart Disease, Stable Angina PectorisView official trial listing → -
Not yet recruiting NCT NCT07378293
Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers
Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 2 sites Stand-aloneOther conditions: Diabete Mellitus, Lipid ProfileView official trial listing → -
Not yet recruiting NCT NCT07389304
[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]
Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 100 participants Est. completion 2027-02-20 1 site Stand-aloneOther conditions: Lipid Profile,Blood PressureView official trial listing → -
Not yet recruiting NCT NCT07462715
Statins Against Bushfire Smoke
Not yet reported Menzies Institute for Medical Research 100 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Healthy AdultsView official trial listing → -
Not yet recruiting NCT NCT07474649
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
Not yet reported Daiichi Sankyo 103 participants Est. completion 2028-10-02 12 sites Stand-aloneOther conditions: Coronary Atherosclerosis, Mixed Dyslipidemia, HypercholesterolemiaView official trial listing → -
Completed NCT NCT07489183
A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older
Dong Wha Pharmaceutical Co. Ltd. 641 participants Est. completion 2023-09-07 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT07497776
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
Not yet reported National Institute of Kidney Disease and Urology (NIKDU) 100 participants Est. completion 2025-10-31 1 site Stand-aloneOther conditions: DyslipidaemiaView official trial listing → -
Not yet recruiting NCT NCT07502001
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 42 participants Est. completion 2027-06-02 1 site Stand-aloneOther conditions: Overweight, ObesityView official trial listing → -
Not yet recruiting NCT NCT07508254
Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome
Not yet reported Punjab Institute of Cardology 120 participants Est. completion 2026-10-31 1 site Stand-aloneOther conditions: Acute Coronary Syndromes (ACS), HypercholesterolemiaView official trial listing → -
Completed NCT NCT07511686
Metabolic and Mitochondrial Changes in Statin-Induced Myopathy
Riga Stradins University 38 participants Est. completion 2024-10-09 1 siteOther conditions: Statin Adverse Reaction, Statin-induced MyopathyView official trial listing → -
Completed NCT NCT07530289
A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)
Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2026-06-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT07534592
A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
Not yet reported AstraZeneca 48 participants Est. completion 2026-10-01 2 sites Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07549932
Adjunctive Role of Statin Therapy on Airway Inflammation and Clinical Consequences of Chronic Obstructive Pulmonary Disease
Not yet reported Mohamed Salah El-Sayed 80 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Statin, Airway Disease, Chronic Obstructive Pulmonary DiseaseView official trial listing → -
Enrolling by invitation NCT NCT07568574
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-aloneOther conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesView official trial listing → -
Completed NCT NCT07578857
Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia
Not yet reported Riphah International University 60 participants Est. completion 2023-10-25 1 siteOther conditions: HyperlipidemiasView official trial listing → -
Not yet recruiting NCT NCT07586540
Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque
Not yet reported Middle East North Africa Stroke and Interventional Neurotherapies Organization 280 participants Est. completion 2030-09 14 sites Stand-aloneOther conditions: Carotid StenosisView official trial listing → -
Not yet recruiting NCT NCT07605130
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial
Not yet reported Peking Union Medical College Hospital 440 participants Est. completion 2029-07-31 1 site Stand-aloneOther conditions: Intracranial Arteriosclerosis, Cognitive ImpairmentView official trial listing → -
Completed NCT NCT07608705
A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants
Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2026-08-24 1 site Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT07624604
Evaluation of the Therapeutic Efficacy of Auricular Pellets Combined With Atorvastatin 20mg in Patients With Dyslipidemia and Phlegm-Dampness Syndrome
Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 80 participants Est. completion 2026-06-10 1 site Stand-aloneOther conditions: Phlegm-Dampness SyndromeView official trial listing → -
Not yet recruiting NCT NCT07626840
Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)View official trial listing → -
Not yet recruiting NCT NCT07630363
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
Not yet reported, Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40 participants Est. completion 2030-04-01 1 site Stand-aloneOther conditions: Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With ImmunotherapyView official trial listing → -
Not yet recruiting NCT NCT07634341
Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.
Not yet reported Fayoum University 80 participants Est. completion 2027-12 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Not yet recruiting NCT NCT07662525
Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP
Not yet reported Peking University People's Hospital 50 participants Est. completion 2028-12-30 1 site Stand-aloneOther conditions: Immune Thrombocytopenic PurpuraView official trial listing → -
Completed NCT NCT07668076
The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients
Not yet reported Damanhour University 44 participants Est. completion 2024-10-20 1 site Stand-aloneOther conditions: Breast Cancer, Doxorubicin Induced CardiomyopathyView official trial listing → -
Not yet recruiting NCT NCT07685054
To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.
Boryung Pharmaceutical Co., Ltd 12700 participants Est. completion 2029-08-15Other conditions: Essential Hypertension, Primary HypercholesterolemiaView official trial listing → -
Not yet recruiting NCT NCT07699003
Endovascular Treatment of Chronic Intracranial Artery Occlusion
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 382 participants Est. completion 2030-08-01Other conditions: Chronic Intracranial Artery OcclusionView official trial listing → -
Completed NCT NCT07702669
Modified Huanglian Wendan Decoction for Metabolic Syndrome
Not yet reported First Affiliated Hospital of Heilongjiang Chinese Medicine University 180 participants Est. completion 2025-08-31 1 site Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT07712367
Atorvastatin Plus Escitalopram for Depression With Dyslipidemia
Hengshui City Seventh People's Hospital 60 participants Est. completion 2026-05-27 1 siteOther conditions: Depressive Episode, DyslipidemiaView official trial listing → -
Completed NCT NCT07717788
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Osteoporosis, Postmenopausal, Statin TherapyView official trial listing → -
Not yet recruiting NCT NCT07762105
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease
Not yet reported Banu Aji Dibyasakti 64 participants Est. completion 2027-09-30 1 site Stand-aloneOther conditions: Thyroid Eye Disease, Graves Ophthalmopathy, Graves OrbitopathyView official trial listing → -
Not yet recruiting NCT NCT07784608
A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers
Not yet reported Huons Co., Ltd. 28 participants Est. completion 2027-11 1 site Stand-aloneOther conditions: Drug-drug InteractionsView official trial listing → -
Not yet recruiting NCT NCT07799779
Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
Not yet reported Seoul National University Bundang Hospital 294 participants Est. completion 2029-09 1 site Stand-aloneOther conditions: Acute Coronary Syndromes (ACS)View official trial listing → -
Not yet recruiting NCT NCT07815704
Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin
Not yet reported University of Colorado, Denver 40 participants Est. completion 2031-08 1 site Stand-aloneOther conditions: Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer, High Grade Serous Adenocarcinoma of OvaryView official trial listing → -
Not yet recruiting NCT NCT07819643
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Not yet reported Keqiang Zhao 120 participants Est. completion 2029-12-01 Stand-aloneOther conditions: Atherosclerosis Cerebral, Carotid Plaque, Vulnerable Plaque, Carotid StenosisView official trial listing → -
Not yet recruiting NCT NCT07840950
Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study
Not yet reported Xiangya Hospital of Central South University 200 participants Est. completion 2029-01-31 Stand-aloneCardiovascular disease Other conditions: Carotid Artery Plaques, AtherosclerosisView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Atorvastatin Calcium Trihydrate, Atorvastatin calcium, Amlodipine and Atorvastatin, Atorvastatin, Atorvastatin Calcium Tablets, Atorvastatin 20 mg
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
